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A B S T R A C T
Background
Pressure ulcers (also known as bedsores, pressure sores, decubitus ulcers) are areas of localised damage to the skin and underlying tissue
due to pressure, shear or friction. They are common in the elderly and immobile and costly in financial and human terms. Pressure-
relieving beds, mattresses and seat cushions are widely used as aids to prevention in both institutional and non-institutional settings.
Objectives
This systematic review seeks to answer the following questions:
(1) to what extent do pressure-relieving cushions, beds, mattress overlays and mattress replacements reduce the incidence of pressure
ulcers compared with standard support surfaces?
(2) how effective are different pressure-relieving surfaces in preventing pressure ulcers, compared to one another?
Search strategy
For this second update the Cochrane Wounds Group Specialised Register was searched (28/2/08), The Cochrane Central Register of
Controlled Trials (CENTRAL)(2008 Issue 1), Ovid MEDLINE (1950 to February Week 3 2008), Ovid EMBASE (1980 to 2008
Week 08) and Ovid CINAHL (1982 to February Week 3 2008). The reference sections of included studies were searched for further
trials.
Selection criteria
Randomised controlled trials (RCTs), published or unpublished, which assessed the effectiveness of beds, mattresses, mattress overlays,
and seating cushions for the prevention of pressure ulcers, in any patient group, in any setting. Study selection was undertaken by at
least two authors independently with a third author resolving uncertainty. RCTs were eligible for inclusion if they reported an objective,
clinical outcomemeasure such as incidence and severity of new of pressure ulcers developed. Studies which only reported proxy outcome
measures such as interface pressure were excluded.
Data collection and analysis
Trial data were extracted by one researcher and checked by a second. The results from each study are presented as relative risk for
dichotomous variables. Where deemed appropriate, similar studies were pooled in a meta analysis.
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Main results
For this second update 11 trials met the inclusion criteria bringing the total number of RCTs included in the review to 52.
Foam alternatives to the standard hospital foammattress can reduce the incidence of pressure ulcers in people at risk. The relative merits
of alternating and constant low pressure devices are unclear. There is one high quality trial comparing the different alternating pressure
devices for pressure ulcer prevention which suggests that alternating pressure mattresses may be more cost effective than alternating
pressure overlays.
Pressure-relieving overlays on the operating table have been shown to reduce postoperative pressure ulcer incidence, although two
studies indicated that foam overlays resulted in adverse skin changes. Two trials indicated that Australian standard medical sheepskins
prevented pressure ulcers. There is insufficient evidence to draw conclusions on the value of seat cushions, limb protectors and various
constant low pressure devices as pressure ulcer prevention strategies.
A study of Accident& Emergency trolley overlays did not identify a reduction in pressure ulcer incidence. There are tentative indications
that foot waffle heel elevators, a particular low air loss hydrotherapy mattress and two types of operating theatre overlays are harmful.
Authors’ conclusions
In people at high risk of pressure ulcer development higher specification foam mattresses rather than standard hospital foam mattresses
should be used. The relative merits of higher-tech constant low pressure and alternating pressure for prevention are unclear but
alternating pressure mattresses may be more cost effective than alternating pressure overlays. Medical grade sheepskins are associated
with a decrease in pressure ulcer development. Organisations might consider the use of some forms of pressure relief for high risk
patients in the operating theatre. Seat cushions and overlays designed for use in Accident &Emergency settings have not been adequately
evaluated.
P L A I N L A N G U A G E S U M M A R Y
Can pressure ulcers be prevented by using different support surfaces?
Pressure ulcers (also called bed sores) are ulcers on the skin caused by pressure or rubbing at the weight-bearing, bony points of
immobilised people (such as hips, heels and elbows). Different pressure relieving surfaces (e.g. beds, mattresses, mattress overlays and
cushions) are used to cushion vulnerable parts of the body and distribute the surface pressure more evenly. The review found that people
lying on ordinary foam mattresses are more likely to get pressure ulcers than those on higher specification foam mattresses. Rigorous
research comparing different support surfaces is needed.
B A C K G R O U N D
Description of the condition
Pressure ulcers (also known as pressure sores, decubitus ulcers and
bed sores) are areas of localised damage to the skin and underlying
tissue, believed to be caused by pressure, shear or friction (Allman
1997). They usually occur over bony prominences such as the base
of the spine, hips and heels. Pressure ulcers occur in both hospital
and community settings, most often in the elderly and immobile
(e.g. orthopaedic patients), those with severe acute illness (e.g.
patients in intensive care units) and in people with neurological
deficits (e.g. with spinal cord injuries).
The development of pressure ulcers is relatively common. A re-
view of epidemiological studies in the UK, Canada and the USA
describes reported pressure ulcer prevalence in the UK of be-
tween 4.4% in a community unit up to 37% in palliative care
(Kaltenhalter 2001). In the USA and Canada prevalence ranged
from 4.7% in hospital patients to 33% in spinal cord injured pa-
tients in the community. They represent a major burden of sick-
ness and unmeasured effects on quality of life for patients and
their carers, and are costly to health care systems. In the UK the
cost of preventing and treating pressure ulcers in a 600-bedded
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large general hospital was estimated at between £600,000 and £3
million per year (Clark 1994). The total cost of pressure ulcers to
the NHS has been estimated as £1.4-£2.1 billion annually with
most of this cost being due to nurse time (Bennett 2004). The
extent to which pressure ulcers are preventable is not clear.
Description of the intervention
The aim of pressure ulcer prevention strategies is to reduce the
magnitude and/or duration of pressure between a patient and their
support surface (the “interface pressure”). This may be achieved
by regular manual repositioning (e.g. “two hourly turning”), or by
usingpressure-relieving support surfaces such as cushions,mattress
overlays, replacement mattresses or whole bed replacements. The
cost of these interventions varies widely; from over £30,000 for
some bed replacements to less than £100 for some foam overlays.
Information on the relative cost-effectiveness of this equipment is
clearly needed to aid rational use.
How the intervention might work
Pressure-relieving cushions, beds and mattresses either mould
around the shape of the patient to distribute the patient’s weight
over a larger area (constant low pressure devices) (CLP), or me-
chanically vary the pressure beneath the patient, so reducing the
duration of the applied pressure (alternating pressure devices) (AP)
(Bliss 1993). CLP devices (either overlays, mattresses or replace-
ment beds) can be grouped according to their construction (foam,
foam and air, foam and gel, profiled foam, hammocks, air sus-
pension, water suspension and air-particulate suspension/air-flu-
idised). These devices fit or mould around the body so that the
pressure is dispersed over a large area. Alternating pressure devices
generate alternating high and low interface pressures between body
and support, usually by alternate inflation and deflation of air-
filled cells. Such devices are available as cushions, mattress over-
lays, and single-or multi-layer mattress replacements.
Turning beds, such as turning frames, net beds, and turning/tilting
beds move those patients, either manually or automatically, who
are unable to turn themselves. Pressure ulcer prevention is often
not the reason for using turning and tilting beds; they may be
used in Intensive and Critical Care Units for other reasons, e.g. to
promote chest drainage.
Why it is important to do this review
Health care professionals attempt to reduce the incidence of severe
pressure ulcers by the identification of people at high risk and the
use of prevention strategies, such as pressure-relieving equipment.
It is essential that initiatives are based on the best available evidence
of clinical and cost-effectiveness and we have therefore undertaken
a systematic review of the evidence for the effectiveness of pressure-
relieving support surfaces such as beds, mattresses, cushions, and
repositioning interventions.
O B J E C T I V E S
This systematic review seeks to answer the following questions:
• to what extent do pressure-relieving cushions, beds,
mattress overlays and mattress replacements reduce the incidence
of pressure ulcers compared with standard support surfaces?
• how effective are different pressure-relieving surfaces in
preventing pressure ulcers, compared to one another?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) comparing beds, mattresses
and cushionswhichmeasured the incidence of newpressure ulcers.
Studies which used only subjective measures of outcome (e.g.,
skin condition “better” or “worse”) were excluded, as were studies
which reported only proxy measures such as interface pressure.
There was no restriction on the basis of the language in which the
study reports were written, nor publication status.
Types of participants
Patients receiving health care who were deemed to be at risk of
pressure ulcer development, in any setting.
Types of interventions
Studies which evaluated the following interventions for pressure
ulcer prevention were included:
Low-tech CLP support surfaces:
• Standard foam mattresses
• Alternative foam mattresses/overlays (e.g. convoluted foam,
cubed foam): these are conformable and aim to redistribute
pressure over a larger contact area
• Gel-filled mattresses/overlays: mode of action as above
• Fibre-filled mattresses/overlays: mode of action as above
• Air-filled mattresses/overlays: mode of action as above
• Water-filled mattresses/overlays: mode of action as above
• Bead-filled mattresses/overlays: mode of action as above
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• Sheepskins: proposed mode of action unclear.
High-tech support surfaces:
• Alternating pressure mattresses/overlays: patient lies on air
filled sacs which sequentially inflate and deflate and relieve
pressure at different anatomical sites for short periods; may
incorporate a pressure sensor (AP).
• Air fluidised beds: warmed air circulated through fine
ceramic beads covered by a permeable sheet; allows support over
a larger contact area (CLP).
• Low air loss beds: patients are supported on a series of air
sacs through which warmed air passes (CLP).
Other support surfaces:
• Turning beds/frames: these work by either aiding manual
repositioning of the patient, or by motor driven turning and
tilting.
• Operating table overlays: as above.
• Wheelchair cushions: may be conforming and therefore
reduce contact pressures by increasing surface area in contact, or
mechanical e.g. alternating pressure.
• Limb protectors: pads and cushions of different forms to
protect bony prominences.
Types of outcome measures
Primary outcomes
1. Incidence of new pressure ulcers.
Many evaluations have simply measured the pressure on different
parts of the body in contact with the support surface (interface
pressure). However, interface pressure is an intermediate or sur-
rogate outcome measure which has serious limitations as a proxy
for clinical outcome, since the process which leads to the devel-
opment of a pressure ulcer almost certainly involves the complex
interplay of several factors. Unfortunately, because it is relatively
simple, quick and inexpensive to measure, most evaluations only
compare interface pressure. In this review we have only considered
trials which report the clinical outcome measure of pressure ulcer
incidence.
Some studies, when reporting outcomes of interventions for pre-
vention, did not differentiate between people developing grade 1
ulcers (in which the skin is unbroken) and those developing more
severe ulcers. Studies which compare the incidence of pressure ul-
cers of grade 2 or greater are more likely to be reliable (see below
for details of grading system), however we included all studies ir-
respective of whether grade 1 ulcers were described separately.
2. Grades of new pressure ulcers.
A range of pressure ulcer grading systems is used in pressure ulcer
trials. An example of a commonly used grading system is presented
below:
GRADE 1: Persistent discolouration of the skin including non-
blanchable erythema; blue/purple/black discolouration.
GRADE 2: Partial thickness skin loss involving epidermis and
dermis.
GRADE 3: Full thickness skin loss involving damage or necrosis
of subcutaneous tissues but not through the underlying fascia and
not extending to the underlying bone, tendon or joint capsule.
GRADE 4: Full thickness skin loss with extensive destruction and
tissue necrosis extending to the underlying bone, tendon or joint
capsule.
Secondary outcomes
the following outcomes were also recorded where available:
• Costs of the devices
• Patient comfort
• Durability of the devices
• Reliability of the devices
• Acceptability of the devices
Search methods for identification of studies
Electronic searches
For the second update of this review we searched:
Cochrane Wounds Group Specialised Register (Searched 28/2/
08)
The Cochrane Central Register of Controlled Trials (CENTRAL)
- The Cochrane Library 2008 Issue 1
Ovid MEDLINE - 1950 to February Week 3 2008
Ovid EMBASE - 1980 to 2008 Week 08
Ovid CINAHL - 1982 to February Week 3 2008
The following search strategy was used for CENTRAL and mod-
ified where appropriate for other databases:
#1 MeSH descriptor Beds explode all trees
#2 mattress*
#3 cushion*
#4 “foam” or transfoam
#5 overlay*
#6 “pad” or “pads”
#7 “gel”
#8 pressure NEXT relie*
#9 pressure NEXT reduc*
#10 pressure NEXT alleviat*
#11 “low pressure” NEAR/2 device*
#12 “low pressure” NEAR/2 support
#13 constant NEAR/2 pressure
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#14 “static air”
#15 alternat* NEXT pressure
#16 air NEXT suspension*
#17 air NEXT bag*
#18 water NEXT suspension*
#19 elevation NEAR/2 device*
#20 clinifloat or maxifloat or vaperm or therarest or sheepskin or
hammock or “foot waffle” or silicore or pegasus or cairwave
#21 (turn* or tilt*) NEXT (bed* or frame*)
#22 kinetic NEXT (therapy or table*)
#23 net NEXT bed*
#24 “positioning” or “repositioning”
#25 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR
#9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16
OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR
#24)
#26 MeSH descriptor Pressure Ulcer explode all trees
#27 pressure NEXT (ulcer* or sore*)
#28 decubitus NEXT (ulcer* or sore*)
#29 (bed NEXT sore*) or bedsore*
#30 (#26 OR #27 OR #28 OR #29)
#31 (#25 AND #30)
The MEDLINE search was combined with the Cochrane Highly
Sensitive Search Strategy for identifying randomised trials in
MEDLINE: sensitivity- and precision-maximizing version (2008
revision); Ovid format (Lefebvre 2008). The EMBASE and
CINAHL searches were combined with the trial filters developed
by the Scottish Intercollegiate Guidelines Network (SIGN 2008).
There was no restriction on the basis of the language in which the
study reports were written, nor publication status.
See Appendix 1 for the search strategy used for the first update of
this review.
Searching other resources
Experts in the field of wound care were originally contacted to
enquire about ongoing and recently published trials in the field of
wound care. In addition, manufacturers of wound care materials
were contacted for details of the trials they are conducting. This
process has not been repeated for this update since it was not
productive. However citations within obtained reviews and papers
were scrutinised to identify additional studies.
Data collection and analysis
Selection of studies
For this update the titles and abstracts of the search results were as-
sessed for relevance by three authors (EMcI, SB-S, JD), full copies
of all potentially relevant studies were obtained. Decisions on fi-
nal inclusion after retrieval of full papers was made by one author
(EMcI) and checked by a second author (RL or JD); disagree-
ments were resolved by discussion with a third author (NC or SB-
S). Rejected studies were checked by a third author (one of SB-S;
NC).
Data extraction and management
Data from included trialswere extracted by a single author into pre-
prepared data extraction tables and checked by a second author.
The following data were extracted from each study:
• patient inclusion/exclusion criteria
• care setting
• key baseline variables by group, for example, age, sex,
baseline risk, baseline area of existing ulcers
• description of the interventions and numbers of patients
randomised to each intervention
• description of any co-interventions/standard care
• duration and extent of follow up
• outcomes (incidence and severity of new pressure ulcers)
• acceptability and reliability of equipment if reported
• description of inclusion and exclusion criteria used to derive
the sample from the target population
• description of a priori sample size calculation
• incident ulcers described by severity grading as well as
frequency (Grade 1 ulcers are not breaks in the skin and are
subject to more inter-rater variation)
• clear description of main interventions.
Assessment of risk of bias in included studies
The methodological and reporting quality of each trial were as-
sessed by a single author and checked by a second author. The
following quality criteria were used:
• evidence of true randomisation, for example adequate
sequence generation is reported using random number tables,
computer random number generator, coin tossing, or shuffling.
• evidence of allocation concealment at randomisation, such
as central randomisation; serially numbered, opaque, sealed
envelopes.
• description of baseline comparability of intervention groups
• outcome assessment stated to be blinded
• evidence of an intention to treat analysis (ITT), for example
specifically reported by authors that ITT was undertaken and
this was confirmed on study assessment, or not stated in the trial
report but evident from study assessment that ITT was
undertaken.
• percentage of participants for whom data was complete at
defined study end-point
Dealing with missing data
Where study details or data were missing from reports then at-
tempts were made to contact the study authors to complete the
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information necessary. If studies were published more than once,
the most detailed report was used as the basis of the data extrac-
tion.
Data synthesis
For each trial, relative risk (RR) was calculated for categorical out-
comes such as number of patients developing ulcers. 95% con-
fidence intervals (95% CI) were included when sufficient detail
to allow their calculation was provided. The results from repli-
cated studies were plotted on to graphs and discussed by narra-
tive review. Individual study details are presented in structured
tables (Characteristics of included studies). Where there was more
than one trial comparing similar devices using the same outcome
(though possibly differing lengths of follow up), statistical het-
erogeneity was tested for by I2 (Higgins 2003). In the absence of
significant statistical heterogeneity, studies with similar compar-
isons were pooled using a fixed effects model. If heterogeneity was
observed both random and fixed effects models were used to pool
the data. For the purpose of meta analysis we assumed that relative
risk remained constant for different lengths of follow up, hence we
pooled studies which followed participants for different lengths of
time. All statistical analysis was performed on RevMan 5.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
Fifty two relevant randomised controlled trials met the inclusion
criteria for the review (Characteristics of included studies). Thirty
trials involved participantswithout pre-existing pressure ulcers (in-
tact skin); 4 trials included patients with ulcers greater than stage
1; 5 trials included participants with and without ulcers and in 13
trials the baseline skin status of the participants was unclear.
Study Settings
Five studies evaluated different operating table surfaces (
Aronovitch 1999; Feuchtinger 2006; Nixon 1998; Russell 2000;
Schultz 1999); eight evaluated different surfaces in intensive
care units (ICU) (Cadue 2008; Gentilello 1988; Inman 1993;
Laurent 1997; Sideranko 1992; Summer 1989; Takala 1996;
Theaker 2005); eight studies confined their evaluation to or-
thopaedic patients (Cooper 1998; Exton-Smith 1982; Goldstone
1982; Hofman 1994; McGowan 2000; Price 1999; Santy 1994;
Stapleton 1986) and one involved both an accident and emer-
gency and ward setting (Gunningberg 2000). The remaining stud-
ies looked at a variety of patients, for example those in nursing
homes (n=9) and those on care of the elderly, medical and surgical
wards.
Interventions
Five trials evaluated cushions, three evaluated the use of sheepskins,
and three looked at turning beds/kinetic therapy. The remaining
studies evaluated different mattresses, overlays and beds.
Risk of bias in included studies
A summary of the sample size and methodological quality of each
trial is shown in Table 1.
Although the majority of trials discussed the criteria for including
patients, only approximately 50% of the reports gave information
that indicated that patients were randomly allocated with con-
cealed allocation.
Blinded outcome assessment is rarely used in wound care studies
and this was certainly the case in these evaluations of pressure
relieving surfaces. It can be difficult or impossible to disguise the
surface that a patient is on for assessment of outcome, and patients
are often too ill to be removed from their bed for assessment of
their pressure areas. Nevertheless, some studies minimise bias in
outcome assessment by having a second assessor and presenting
inter-rater reliability data, or by presenting photographic evidence
of pressure area status which can then be assessed by an assessor
blinded to treatment. Of the 52 RCTs in this review, we could be
confident that blinded outcome assessment had been used in only
13 trials.
Small sample size was a major limitation of many of the studies;
the median sample size was 100 (range 12 to 1972) and only 20
studies described an a priori sample size estimate. High attrition
rates and lack of an intention-to-treat analysis were also common.
For most comparisons there is a lack of replication.
In studies of pressure ulcer prevention it is extremely important
for trialists to report on the baseline comparability of the inter-
vention groups for important variables such as baseline risk. Risk
of pressure ulcer development is usually reported as one of various
risk scores such as Norton, Waterlow, Gosnell or Braden. Some of
the studies reviewed here did not present such baseline data nor
explain what the various cut-offs for inclusion in the studies meant
in terms of whether study participants were of low, medium or at
high risk for the development of pressure ulcers. Another short-
coming was being unclear about whether grade 1 pressure ulcers
were included in the study sample and/or analysis.
Effects of interventions
HOW THE RESULTS ARE PRESENTED AND WHAT THE
TERMS MEAN
Results of dichotomous variables are presented as relative risk (RR)
with 95% confidence intervals (CI). Relative risk has been used
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rather than odds ratios as event rates are high in these trials and
odds ratios would give an inflated impression of the magnitude of
effect (Deeks 1998). Relative risk is the pressure ulcer incidence
rate in the experimental group divided by the incidence rate in
the control group and indicates the likelihood of pressure ulcer
development on an experimental device compared with a compar-
ison device. As by definition, the risk of an ulcer developing in the
control group is 1, then the relative risk reduction associated with
using the experimental bed is 1-RR. The relative risk indicates the
relative benefit of a therapy but not the actual benefit, i.e. it does
not take into account the number of people who would have de-
veloped an ulcer anyway. The absolute risk reduction (ARR) can
be calculated by subtracting the incidence rate in the experimental
group from the incidence rate in the control group. The ARR tells
us how much the reduction is due to the bed itself, and its inverse
is the number needed to treat, or NNT. Thus an incidence rate of
30% on a control mattress reduced to 15% with an experimental
mattress translates into an ARR of 30-15=15% or 0.15, and an
NNT of 7, in other words 7 patients would need to receive the ex-
perimental mattress to prevent the development of one additional
pressure ulcer.
Methods for measuring secondary outcomes such as comfort,
durability, reliability and acceptability were not well developed.
Where data was presented it appears in the Characteristics of
included studies, but not incorporated in the analysis.
’Low-tech’ constant pressure supports
This section considers comparisons of standard foamhospital mat-
tresses with other low-technology (low-tech), constant low pres-
sure supports (CLP). We regarded the following as low-tech CLP:
sheepskin, static air-filled supports; water-filled supports; con-
toured or textured foam supports; gel-filled supports; bead-filled
supports; Silicore-filled supports. It should be emphasised how-
ever that there is no international definition of what constitutes a
standard foam hospital mattress and indeed this changes over time
within countries and even within hospitals. Where a description
of the standard was provided it is included in the Characteristics
of included studies. We have assumed that standard mattresses are
likely to vary less within than between countries and undertaken
subgroup analysis by country, however this was not pre-specified.
Standard foam hospital mattress compared with other low-
tech CLP.
Eight RCTs compared ’standard’ mattresses/surfaces with ’low-
tech’ supports for the prevention of pressure ulcers (Andersen
1982; Collier 1996; Goldstone 1982; Gray 1994a; Gunningberg
2000; Hofman 1994; Russell 2002; Santy 1994).
When compared with standard hospital mattresses, the incidence
and severity of pressure ulcers in ’high risk’ patients were reduced
when patients were placed on either the Comfortex DeCube mat-
tress (Hofman 1994)(RR0.34, 95%CI0.14 to 0.85); theBeaufort
bead bed (Goldstone 1982)(RR 0.32, 95%CI 0.14 to 0.76); the
Softform mattress (Gray 1994a) (RR 0.2, 95%CI 0.09 to 0.45);
or the water-filled mattress (Andersen 1982) (RR 0.35, 95%CI
0.15 to 0.79)(Analysis 1.1).
In an unpublished British study of older people with hip frac-
tures admitted to orthopaedic trauma wards, patients allocated to
receive the then NHS standard foam mattress (manufactured by
Relyon) experienced over three times the rate of pressure ulcers as
those using one of a number of foam alternatives (Clinifloat, Ther-
arest, Transfoam and Vaperm) (Santy 1994) (RR 0.36, 95%CI
0.22 to 0.59). Another study found a significant decrease in the
incidence of grade I pressure ulcers from 26.3% to 19.9% (p=
0.0004) and a non-significant decrease in the incidence of pressure
ulcers grade II to IV from 10.9% to 8.5% in patients allocated to
the high-specification foam mattress/cushion (RR 0.78; 95%CI
0.55 to 1.11) (Russell 2002). No patient developed a pressure ul-
cer in the Collier 1996 trial. The comparisons were considered too
heterogeneous to pool these 7 studies (Analysis 1.1).
Gunningberg 2000 examined the effects of a viscoelastic foam
trolley mattress and subsequent overlay on 101 patients with a
suspected hip fracture in the A&E and ward setting. There was
no significant difference in pressure ulcer incidence between those
assigned a visco-elastic foam trolley mattress on arrival in A&
E followed by a viscoelastic foam overlay on the standard ward
mattress (4/48, 8%) and those assigned a standard trolleymattress
and then a standard hospital mattress on the ward (8/53, 15%).
The five trials comparing foam alternatives with the standard hos-
pital foam mattress (Collier 1996; Gray 1994a; Hofman 1994;
Santy 1994; Russell 2002) were pooled using a random effects
model (I2 =77%). These trials were of mixed quality; they all pro-
vided evidence of allocation concealment but none used blinded
outcome assessment. To avoid double counting the control pa-
tients in the trials with more than 2 comparisons, and in the ab-
sence of major differences between the effects of different foams,
the foam alternatives were pooled. This approach maintains the
randomisation but results in comparison groups of unequal size.
This analysis yielded a pooled relative risk of 0.40 (95%CI 0.21
to 0.74), or a relative reduction in pressure ulcer incidence of
60% (95%CI 26% to 79%)(Analysis 2.1). Concern regarding the
heterogeneity in standard hospital mattress between these trials
led us to undertake a separate meta analysis of UK based studies
(where variation in the standard hospital mattress is likely to be
lower). Pooling the 4 studies which compared alternative foam
supports with standard foam mattresses in the UK (Collier 1996;
Gray 1994a; Russell 2002; Santy 1994) resulted in the significant
benefit of alternative foam over standard foam being maintained
(RR 0.41, 95%CI 0.19 to 0.87) (Analysis 2.2). Therefore foam
alternatives to the standard hospital mattress can reduce the inci-
dence of pressure ulcers in at risk patients, including patients with
fractured neck of femur.
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Comparisons between Alternative foam mattresses
This section covers results of studies which performed head-to-
head comparisons of high-specification foam products (i.e. con-
toured foam, supports comprising foam of different densities).
Five RCTs (Collier 1996; Gray 1994a; Kemp 1993; Santy 1994;
Vyhlidal 1997) compared different foam alternatives (Analysis
3.1).
Santy 1994 and colleagues compared 5 alternative foammattresses
(Clinifloat, Vaperm, Therarest, Transfoam, NHS standard foam)
and found significant reductions in pressure ulcer incidence associ-
ated with Clinifloat, Therarest, Vaperm and Transfoam compared
with standard; and Vaperm compared with Clinifloat (RR 0.36,
95%CI 0.22 to 0.59). Vyhlidal 1997 compared a 4 inch thick
foam overlay (Iris 3000) with a foam and fibre mattress replace-
ment (Maxifloat) and reported a significant reduction in pressure
ulcer incidence (RR 0.42, 95%CI 0.18 to 0.96) with the mattress
replacement, however this trial appeared to have used neither al-
location concealment nor blinded outcome assessment.
Kemp1993 compared a convoluted foamoverlaywith a solid foam
overlay in only 84 patients and found no significant difference
in pressure ulcer incidence rates however this may be a Type 2
error, in other words the small sample size may have precluded
detection of a significant difference (RR 0.66, 95% CI 0.37 to
1.16). Gray 1994b compared the Transfoam and Transfoamwave
foam mattresses however only 1 patient in each group developed
a ulcer.
Comparisons between ’Low-tech’ Constant Low Pressure
Supports:
This section covers head-to-head comparisons of the following
types of support: foams; static air-filled supports (including dry
flotation); water-filled supports; gel-filled supports; Silicore-filled
supports; heel elevators and sheepskins (Analysis 4.1).
Eleven RCTs have compared different low-tech CLP devices for
prevention (Cadue 2008; Cooper 1998; Ewing 1964; Gilcreast
2005; Jolley 2004; Lazzara 1991; McGowan 2000; Sideranko
1992; Stapleton 1986; Takala 1996; Tymec 1997). Most of these
trials are underpowered and/or have other methodological flaws.
A trial from Finland (Takala 1996) comparing the Optima (Car-
ital) constant low pressure mattress - which comprises 21 double
air bags on a base - with the standard hospital mattress found
that significantly more patients (37%) on the standard mattress
developed ulcers compared with none on the Optima (RR 0.06;
95%CI 0 to 0.99). The report of this study did not describe either
allocation concealment or blinded outcome assessment.
The remaining trials (Cooper 1998; Lazzara 1991; Sideranko
1992; Stapleton 1986) were all unique comparisons with low
power and none found statistically significant differences between
the surfaces tested (Analysis 4.1).
Heel devices
One trial (52 patients) compared a proprietary heel elevation de-
vice (FootWaffle) comprising a vinyl boot with built in foot cradle,
with elevation of the heels using a hospital pillow (Tymec 1997).
The study reported that more heel ulcers developed in the group
using the Foot Waffle (n=6) compared with the group using a
hospital pillow)(n=2) although this difference was not statistically
significant and the number of people in each group was not clearly
reported.
Gilcreast 2005 assessed three heel pressure relief devices: theBunny
Boot (fleece) high cushion heel protector; the egg-crate heel lift
positioner and the foot waffle air cushion. There were no statisti-
cally significant differences between the devices in terms of pres-
sure ulcer incidence (3/77, 4% for the bunny boot; 4/87, 4.6% for
the egg crate and 5/76, 6.6% for the foot waffle). However, it was
not clear from the trial whether the number of incident ulcers or
number of participants with incident ulcers was being reported.
Furthermore, the analysis of this trial was not by intention to treat,
and 30% of data were not included in the analysis due, in part to
non-compliance.
Sheepskins
Three trials have examined the effects of sheepskins on pressure
ulcer incidence. The first (Ewing 1964) comparing the standard
hospital mattress with and without sheepskin overlays, was consid-
ered too small and poorly designed to detect a difference. The sec-
ond involving 297 orthopaedic patients (McGowan 2000) found
that pressure ulcer incidence was significantly reduced in those as-
signed an Australianmedical sheepskin (RR for sheepskins relative
to standard treatment was 0.30 (95% CI 0.17 to 0.52). The third
by Jolley 2004 conducted a study on a mixed inpatient population
of a metropolitan hospital comparing a sheepskin mattress over-
lay with ‘usual care’ which included repositioning and any other
pressure relieving devices with or without low-tech constant pres-
sure relieving devices. It seems that analysis by intention to treat
was not used as 539 participants were randomised but only 441
analysed. The study states that any patient whose risk increased
to high as measured by Braden score <12 for 48 hours was no
longer followed up. The rationale for this is not clear. The results
for Grade 2 or above pressure ulcers were 12/218 (5.5%) for the
sheepskin group and 20/223 (9%) for the ‘usual care’ group (re-
ported denominators). The participant incidence rate ratio for all
ulcer grades was 0.58 (95% CI 0.35 to 0.96). Pooling these two
trials using a random effects model (I2 = 67%) showed there were
statistically significantly fewer pressure ulcers in the group using
sheepskins (RR 0.42 95% CI 0.22 to 0.81)(Analysis 4.1).
Body support
One trial with 70 intensive care unit participants (Cadue 2008)
compared a foam body support and usual care (half-seated posi-
tion, water mattress and preventative massage 6 times a day) with
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usual care alone for the prevention of heel ulcers. In total 8.6%
(3/35) of participants in the support group developed heel ulcers
(all grades) compared with 55.4% (19/35) in the control group,
this difference was statistically significant (RR: 0.15 95% CI 0.05
to 0.47) (Analysis 4.1).
’High-tech’ pressure supports
Alternating Pressure Supports:
A variety of alternating pressure (AP) supports is used in hospital
and community. The depth of the air-cells, cell cycle time and
mechanical robustness vary between devices and these factors may
be important in determining effectiveness. It is worth emphasising
that most of the RCTs of AP supports did not adequately describe
the equipment being evaluated, including the size of the air cells
and cell cycle time.
Sixteen RCTs of alternating pressure supports for pressure ulcer
prevention were identified: these compared AP and standard hos-
pital mattresses in two studies (Andersen 1982; Sanada 2003);
AP and various constant low pressure devices in nine studies
such as water (Andersen 1982; Sideranko 1992), static air (Price
1999; Sideranko 1992), Silicore (Conine 1990; Daechsel 1985;
Sideranko 1992), foam (Sideranko 1992; Whitney 1984), various
(Gebhardt 1994; Laurent 1997); visco-elastic foam (Vanderwee
2005); continuous lowpressure (Cavicchioli 2007), andwith other
alternating pressure supports in five studies (Exton-Smith 1982;
Hampton 1997; Nixon 2006; Taylor 1999; Theaker 2005).
Alternating Pressure Compared With Standard Hospital
Mattress
Andersen 1982 reported that the use of alternating pressure sur-
faces significantly reduces the incidence of pressure ulcers com-
pared with standard hospital mattresses (RR 0.32, 95% CI 0.14
to 0.74). This report of this large trial, involving 482 patients
at ’high-risk’ of pressure ulcers, gave no indication that either al-
location concealment or blinded outcome assessment had been
used. In an underpowered and unblinded study conducted on pa-
tients requiring head elevation, Sanada 2003 compared: the Air
Doctor (a single layer air cell overlay); the Tricell (a double-layer
cell overlay), (both with 5-minute alternating air pressure) and a
Paracare (standard hospital mattress). In the Sanada trial both the
experimental groups and control group had a two-hourly change
of position and skin care. In the Air Doctor group 4/29 (13.8%)
participants developed grade 2 pressure ulcers, in the Tricell group
1/26 (3.8%) participants developed grade 2 pressure ulcers; and
in the Paracare group 6/27 (22%) participants developed grade 2
pressure ulcers. The number of grade 1 ulcers was also reported in
the study.The denominators are numbers presented by the authors
after withdrawals and attrition and the study was not analysed by
intention to treat.
These two trials were pooled using a fixed effects model (I2 =
0%), there was a statistically significant reduction in pressure ulcer
development with the AP surface compared with the standard
hospital mattress (RR 0.31, 95% CI 0.17 to 0.58), however it
should be recognised that these trials are of poor quality (Analysis
5.1).
Alternating Pressure Compared With Constant Low Pressure
Ten trials compared AP devices with various constant low pressure
devices, however there is conflicting evidence as to their relative
effectiveness. One study compared a range of AP supports with
a range of CLP supports in a range of specialties in acute care
settings (Gebhardt 1994) and reported significantly more pressure
ulcers in patients in the CLP group (34% compared with 13%
in the AP group) (RR 0.38, 95%CI 0.22 to 0.66)(Analysis 6.1).
This trial is difficult to interpret given the wide variety of surfaces
used within the study, there is currently insufficient evidence to
support a ’class effect’ for all alternating pressure devices and all
constant low pressure devices.
In contrast, nine RCTs comparing different types of AP supports
and a variety of constant low pressure devices such as the Sil-
icore overlay (Conine 1990; Daechsel 1985; Stapleton 1986), a
water mattress (Andersen 1982; Sideranko 1992), a foam pad
(Stapleton 1986; Whitney 1984), and static air mattresses (Price
1999; Sideranko 1992), a visco-elastic foam mattress (including 4
hourly turning and a sitting protocol with a cushion)(Vanderwee
2005), continuous pressure mode of the Hill-Rom Duo mattress
(Cavicchioli 2007), individually reported no difference in effec-
tiveness, although many were too small to be able to detect clini-
cally important differences as statistically significant. In the Van-
derwee study a sub-group analysis on the location of pressure ul-
cers reported there were statistically significantly more heel pres-
sure ulcers in the control group using the viscoelastic mattress (p
= 0.008 Fischer’s exact test). The study authors also noted that pa-
tients nursed on the experimental equipment (Huntleigh APAM,
Alpha X-cell) seemed to develop more severe ulcers (Analysis 6.1).
Four studies which compared AP with Silicore or foam over-
lays were pooled (Conine 1990; Daechsel 1985; Stapleton 1986;
Whitney 1984). To avoid double counting of the patients in the
AP arm of the Stapleton 3-arm trial, and in the absence of obvi-
ous heterogeneity in the outcomes for Silicore and foam, the Sil-
icore and foam arms were pooled against the AP arm (maintain-
ing the randomisation, avoiding double counting, but resulting in
unequal comparison groups). Overall the pooled relative risk of
pressure ulcer development for AP comapred with Silicore or foam
overlays (using a fixed effects model; I2 = 0%) was 0.91, (95%
CI 0.71 to 1.17) indicating no statistically significant difference
between Silicore or foam overlays and AP (Analysis 6.1).
The studies which compared AP with static water or static air mat-
tresses were similarly considered together (Andersen 1982; Price
1999; Sideranko 1992). The Sideranko trial also had 3 compar-
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ison groups and for the purposes of the meta-analysis, the water
and static air arms of this study were considered sufficiently sim-
ilar to pool together against AP to avoid double counting of the
AP patients. Pooling these three trials to answer the question of
whether AP is associated with fewer incident ulcers than air or
water filled mattresses using a random effects model (I2 = 25%)
yielded a pooled RR of 1.31 (95% CI 0.51 to 3.35) indicating
no statistically significant difference (Analysis 6.3).
It is worth emphasising, however, that all these studies were small,
and, even when pooled were too underpowered to detect clinically
important differences in effectiveness as statistically significant.
All nine RCTs comparing the various CLP devices and AP devices
were pooled to try to answer the question of whether AP is more
effective than CLP in pressure ulcer prevention. Double counting
was avoided for the Sideranko and Stapleton trials as before. In
view of the different devices evaluated in the studies, the I2 of 34%
and the Chi-square of 13.69 (df=9), a random effects model was
applied. This yielded an overall relative risk of 0.85 (95% CI 0.64
to 1.13) suggesting no statistically significant difference between
the rates of pressure ulcer incidence on AP compared with CLP
(Analysis 6.1). Further trials are needed to determine whether
the CLP and AP devices are associated with a clinically important
difference in risk of pressure ulceration.
One trial used a complex factorial design to compare various
combinations of standard, constant low pressure and alternating
pressure support in surgical intensive care patients intra- and post-
ICU. This trial (which involved only 75 to 80 patients in each
group) did not identify any significant benefit associated with us-
ing alternating pressure in the ICU (Laurent 1997) (Analysis 7.1).
Comparisons between Different Alternating Pressure Devices
Alternating pressure devices differ somewhat in structure, e.g., the
size of the inflatable air cells. One early study of pressure ulcer pre-
vention (Exton-Smith 1982) compared two large-celled alternat-
ing pressure devices (Pegasus Airwave and the Large Cell Ripple
- similar except the Airwave has two layers of cells). The authors
reported that the Airwave System was significantly more effective
than the Large Cell Ripple in preventing and reducing severity of
pressure ulcers in a high risk group of elderly patients. However,
the allocation was not truly random, and an intention-to-treat
analysis would not have shown a statistically significant difference
in the rate of pressure ulcers (16% vs 34%, P >0.05).
Hampton 1997 compared the Pegasus Airwave mattress with a
new Cairwave Therapy system by the same manufacturer, in 75
patients. No patients developed an ulcer in either arm of this study.
Taylor 1999 compared the Pegasus Trinova 3-cell alternating pres-
sure air mattress plus a pressure redistributing cushion (interven-
tion) with a 2-cell alternating pressure air mattress plus a pressure
redistributing cushion (control). This study was underpowered to
detect important differences (22 patients in each group) andwhilst
two patients developed a superficial ulcer in the control group and
none in the intervention group, this difference was not statistically
significant (RR 0.20 95% CI 0.01 to 3.94)(Analysis 8.1).
In an underpowered trial, Theaker 2005 examined two AP devices
in an ICU setting. The KCI Therapulse, a stand alone unit that
incorporates a mattress into a bed frame and which uses optional
pulsation technology and low air loss to reduce tissue interface
pressure and the Hill-Rom Duo mattress (control) which is de-
signed to lay directly onto most standard hospital frames and uses
either continuous or alternating low pressure modes. Details of
the alternating cycle were not provided. Pressure ulcer incidence
(restricted to grade 2 ulcer or greater) was 3/30 (10%) in the ex-
perimental group and 6/32 (19%) in the control group (no statis-
tically significant difference).
In a large, high quality trial Nixon 2006 compared an AP over-
lay with an AP mattress, the primary outcome was pressure ul-
cer (grade 2 or above) incidence. An intention to treat analysis
was conducted on data from 1971 participants (989 in the over-
lay group and 982 in the mattress group). One hundred and six
(10.7%) people in the overlay group and 101 (10.3%) people in
themattress group developed one or more new grade 2 pressure ul-
cers. The majority of incidence ulcers were grade 2..There was no
significant difference between the two groups in terms of develop-
ment of a new pressure ulcer of grade 2 or greater (RR 1.04, 95%
CI 0.81 to 1.35). More participants cared for on the overlay re-
quested a change to another device due to dissatisfaction (23.3%)
compared to mattress patients (18.9%), a statistically significant
difference.
Nixon 2006 also conducted a full cost effectiveness analysis from
the perspective of the UK NHS and Personal Social Service. Cost
information was calculated based on length of hospital stay and
pressure-relieving surface used. Benefits were measured as num-
ber of pressure ulcer free days. In the base case analysis the mean
per patient cost of the AP mattresses was £6509.73 and the mean
patient cost of the AP overlays was £6793.33. The mattress cost
on average £283.6 less per patient, (95%CI, £377.59 to £976.79)
and also conferred greater benefits (a delay in mean time to ulcer-
ation of 10.64 days (95% CI, 24.40 to 3.09). Whilst neither the
difference in costs or benefits reached statistical significance the
assessment of uncertainty around the cost effectiveness decision
indicated that, on average, AP mattresses were associated with an
80% probability of being cost saving. This was because the mat-
tress was associated with a delay in ulceration (measured by Kaplan
Meier estimates) and reduced costs as a consequence of shorter
length of hospital stay. The conclusions of the base case analysis
was not altered when challenged in sensitivity analyses.
Low Air-Loss Beds
One trial reported that low air-loss beds were more effective at
decreasing the incidence of pressure ulcers in critically ill patients
than a standard (but poorly described) ICU bed (RR 0.24, 95%
CI 0.11 to 0.53) (Inman 1993)(Analysis 9.1). A second trial of
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98 participants, compared low air loss hydrotherapy (LAL-hydro)
with standard care (some patients received alternating pressure in
this group); more patients developed ulcers of grade 2 ulcer or
greater in the LAL-hydro group (19%) than the standard care
group (7%) though this difference was not statistically significant
(Bennett 1998) (Analysis 9.1). A third trial with 123 participants
recruited from hospital wards and intensive care units compared a
low air-loss bed (KinAir) with a static air overlay in the prevention
of pressure ulcers (Cobb 1997). Three grade 1 ulcers developed
on the low air-loss bed (3/62) compared with 1 on the static air
overlay (1/61). However, three grade 2 ulcers developed on the
low air-loss bed (3/62) compared with 11 on the static air overlay
(11/61). Comparing the incidence of all ulcers showed no statisti-
cally significant difference between the two groups (Analysis 9.1).
Pooling the two trials which compared low air-loss beds (Cobb
1997; Inman 1993) showed a statistically significant difference in
favour of the low air-loss bed, RR 0.33 95% CI 0.16 to 0.67 (ran-
dom effects I2 = 26%) (Analysis 9.2). Inman 1993 also reported
that low air-loss beds reduced the incidence of patients developing
multiple pressure ulcers compared with the standard ICUmattress
(RR 0.08 95% CI 0.01 to 0.62) (Analysis 9.3).
Air Fluidised Beds compared with Dry Flotation
One small trial in patients after plastic surgical repair of pressure
ulcers showed no difference between an air-fluidised bed and the
Roho dry flotation mattress in post-operative tissue breakdown
rates (Economides 1995) (Analysis 10.1).
Other pressure supports
Kinetic Turning Tables
Turning beds contain motors which constantly turn and tilt the
patient, and are used in critical care settings primarily to prevent
pneumonia and atelectasis. Four RCTs were identified in a meta-
analysis of kinetic therapy (Choi 1992) however full copies of only
two of the individual trials could be obtained for this systematic
review (Gentilello 1988; Summer 1989). Sample sizes in all the
trials was small, and no beneficial effect of kinetic therapy on
pressure ulcer incidence was detected (Analysis 11.1).
Profiling Beds
Keogh 2001 recruited 70 participants and found no pressure ul-
cers developed in either the group assigned the profiling bed with
a pressure reducing foam mattress/cushion combination nor the
group assigned a flat-based bed with a pressure-relieving/redis-
tributing foam mattress/cushion combination.
Operating Table Overlays
Five RCTs have evaluated different methods of pressure relief on
the operating table. The first compared a viscoelastic polymer pad
with a standard table and found a relative reduction in the in-
cidence of post-operative pressure ulcers of 47% associated with
using the polymer pad for patients undergoing elective major gen-
eral, gynaecological or vascular surgery (supine or lithotomy) (RR
0.53; 95% CI 0.33 to 0.85) (Nixon 1998)(Analysis 12.1). It is
important to note that the majority of incident pressure ulcers
were grade 1 (i.e. early ulcers with no break in skin).
Another trial (Feuchtinger 2006) compared an operating theatre
table which included a waterfilled warming mattress, a 4cm ther-
moactive viscoelastic foam overlay with an operating theatre table
with waterfilled warming mattress only. The trial was terminated
before the full sample was recruited because more patients in the
experimental group with the 4-cm thermoactive viscoelastic foam
overlay suffered pressure ulcers (all were Grade 1 to 2), with 13/85
(15%) in the experimental group and 9/90 (10%) in the control
group. In terms of grade 2 only pressure ulcers there were 2 in
the experimental group and 1 in the control group. There was no
statistically significant difference between the two groups at the
point at which the trial was terminated.
Two further RCTs compared the Micropulse alternating system
(applied both during surgery and post-operatively) with a gel pad
during surgery and standard mattress post-operatively. We pooled
these two trials (I2= 0%) and derived a pooled relative risk (fixed
effects) of 0.21, (95% CI 0.06 to 0.7) in favour of the Micropulse
system (Aronovitch 1999; Russell 2000). It is not clear from these
2 trials whether the effect is due to the intra-operative or the post-
operative pressure relief, or both (Analysis 13.1).
Schultz 1999 compared a mattress operating theatre overlay with
usual care (which included padding as required, for example gel
pads, foam mattresses). People in the overlay group were more
likely to experience postoperative skin changes, and six patients in
the overlay group developed ulcers of grade 2 or more compared
with 3 people with ulcers of grade 2 or more in the control group.
No attempt was made to gather information on postoperative skin
care of the patient. Details regarding stage of ulcer by group and
of the unnamed product have been sought from the study authors
with no success. In the absence of this information, the clinical
importance of the findings is difficult to assess.
Overlay used on Accident & Emergency trolleys
Gunningberg 2000 examined the effects of a viscoelastic foam
trolley mattress and subsequent overlay on 101 patients with a
suspected hip fracture in the A&E and ward setting, this trial is
dealt with in the review in the section: Standard foam hospital
mattress compared with other low-tech CLP .
Seat Cushions
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There have been four RCTs comparing different types of seating
cushion for preventing pressure ulcers; one study compared slab
foam with bespoke contoured foam and found no difference be-
tween the groups (RR 1.06, 95% CI 0.75 to 1.49)(Lim 1988).
The second study (Conine 1994) compared the Jay gel and foam
wheelchair cushion with a foam cushion in 141 people and found
fewer ulcers in the Jay cushion group, though this did not reach
statistical significance (RR 0.61, 95% CI 0.37 to 1.00). The third
study (Conine 1993) found no difference in pressure ulcer inci-
dence between those assigned a slab foam cushion bevelled at the
base and those assigned a contoured foam cushion with a poste-
rior cut out (Graph: Comparison 14, Outcome 1). The fourth
study was a small pilot trial of 32 wheelchair users which com-
pared a standard foam (eggcrate) cushion with a pressure reducing
wheelchair cushion (Geyer 2001). The trial did not differentiate
between patients with grade 1 ulcers or higher grades. In total,
40% of participants on the pressure reducing cushion developed
an ulcer (6/15) compared with 58.5% (10/17) on the foam cush-
ion and this difference was not statistically significant (Analysis
14.1).
Summary of Results
Foam alternatives to the standard hospital foam mattress can re-
duce the incidence of pressure ulcers in people at risk.
The relative merits of alternating and constant low pressure de-
vices, and of the different AP devices for pressure ulcer preven-
tion are unclear. One large, high quality study found no signifi-
cant differences between an alternating pressure overlay with an
AP mattress. However, the AP mattresses were associated with an
80% probability of being cost saving, due to a delay in pressure
ulceration and reduced length of stay in hospital.
Pressure-relieving overlays on the operating table and in the post-
operative period have been shown to reduce the postoperative pres-
sure ulcer incidence, although there is some evidence that certain
OR overlays may result in post-operative skin changes
There is insufficient evidence to determine the value of seat cush-
ions, various constant low pressure devices and A&E trolley over-
lays as pressure ulcer prevention strategies.
Two trials investigating the effectiveness of a specific sheepskin
product in preventing pressure ulcers show that sheepskin overlays
are effective in reducing the incidence of pressure ulcers.
D I S C U S S I O N
The confidence with which we can draw firm conclusions from
the studies detailed in this review is greatly tempered by (a) the
poor quality of many of the trials; (b) the lack of replication of
most comparisons and (c) that the ‘standard’ mattress is often
not clearly defined. The clearest conclusion one can draw is that
standard hospital mattresses have been consistently outperformed
by a range of foam-based, low pressure mattresses and overlays,
and also by ’higher-tech’ pressure-relieving beds and mattresses in
the prevention of pressure ulcers.
The application of this conclusion to current clinical practice is
however hampered by the fact that the “standard” was poorly
described in many of these studies, and what is standard varies
by hospital, country and over time. This factor leads to major
difficulties in interpretation of trial results and the importance of
clear descriptions of all interventions in future studies cannot be
overemphasised. In view of this and because we thought there
would be less variationwithin a country, a subgroup analysis ofUK
based studies was undertaken, which showed that the advantage
of alternative foam was maintained. Further, the effects of using
alternative foam mattresses are noteworthy in their consistency.
Many of the trials reviewed did not provide convincing reassurance
that manual repositioning was provided equally to each group
of participants. This is a possible confounder as care providers
were not blinded to treatment allocation in any of the trials, and
may have moved patients in one group more frequently if they
perceived a particular mattress to be less effective. As experimental
evidence of the effectiveness of manual repositioning is lacking
it is difficult to say what impact this has. In addition, in many
studies the definitions of ‘pressure ulcer free’, low-risk, moderate-
risk and high-risk vary widely. Frequently, it is also often difficult
to ascertain whether study participants with Grade 1 ulcers have
been accepted into the sample and included in the analyses or not.
The results of 3 of the 5 trials evaluating the use of pressure-reliev-
ing overlays on the operating table suggest that these are beneficial
in reducing subsequent pressure ulcer incidence in high risk sur-
gical patients. These 3 trials were of reasonable or good quality;
the Nixon 1998 trial particularly was adequately powered with
allocation concealment and blinded outcome assessment, lending
further weight to the result. At present, the most effective means
of pressure relief on the operating table is unclear; Nixon and col-
leagues found a gel-filled overlay to be significantly better than a
standard operating table, whilst a gel-filled overlay on the oper-
ating table was less effective than an alternating pressure overlay
intra- and post-operatively (the Micropulse system) in the other
2 trials. The Micropulse trials are confounded by their provision
of a standard mattress post-operatively in the gel overlay arm, and
an alternating pressure overlay post-operatively in the Micropulse
arm. Thus whilst there is clearly a reduction in pressure ulcer in-
cidence associated with the alternating pressure system, it is not
clear whether this is merely a result of better postoperative pressure
relief. Two other trials (Schultz 1999; Feuchtinger 2006) showed
that post-operative skin changes occurred as a result of different
operating theatre overlays but the clinical importance of these re-
sults is difficult to ascertain in the absence of further details on the
results and products.
One study suggests that low air-loss beds are more effective than
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standard foam ICUbeds in preventing pressure ulcers for people in
ICU beds, however the ICU bed was not described. Another ICU
based study found no differences between a low air loss unit and a
mattresses that used either continuous or alternative low pressure
modes. There are no studies comparing low air-loss therapy with
alternating pressure surfaces and other ’high tech’ low pressure
supports.
Previously the evidence for different alternating pressure devices
was unclear due to the poor quality and small size of existing
studies. This update includes a large and robust trial which suggests
that AP mattresses are clinically as effective as overlays but likely
to be more cost effective and more acceptable to patients (Nixon
2006).
Water-filled and bead-filled mattresses were both associated with
reductions in the incidence of pressure ulcers compared with stan-
dard hospital mattresses, in trials published in the early 1980s.
However, the particular products evaluated are no longer available.
There are tentative indications that four interventions may be
harmful. Firstly, Foot Waffle heel elevators were associated with
a trebling in the incidence of pressure ulcers that did not reach
statistical significance due to the small sample size of the study.
Secondly low air loss hydrotherapy which was evaluated in a trial
in which 19% LAL-hydro patients developed ulcers compared
with 7% of standard care patients - again not a statistically sig-
nificant difference possibly as a result of the small size of the trial
(98 patients in total). Thirdly, Schultz 1999 investigated the ef-
fectiveness of an alternative foam overlay used in the operating
theatre. Results suggest that patients placed on the intervention
devices were significantly more likely to experience postoperative
skin changes (i.e. mainly grade 1 pressure ulcers). However, it is
difficult to separate out the role of postoperative care and padding
which was used as a concomitant intervention, either of which
may have caused the skin changes (mainly found on buttock and
coccyx). Lastly Feuchtinger 2006 terminated the trial of an op-
erating theatre table which included a waterfilled warming mat-
tress and a 4cm thermoactive viscoelastic foam overlay compared
with an operating theatre table with waterfilled warming mattress
only. The trial was terminated before the full sample was recruited
because more patients in the experimental group with the 4-cm
thermoactive viscoelastic foam overlay suffered pressure ulcers (all
were Grade 1 to 2).
Few comparisons have been replicated, and as most of the tri-
als undertaken are under-powered there is little information from
which to draw firm conclusions. For example, air fluidised ther-
apy as a prevention strategy has only been compared with dry
flotation, and low air loss only with standard care, in one trial,
as an intervention. There remain gaps in the knowledge base to
which a rational research agenda could be developed. It is always
important to consider publication bias and its potential influence
on the population of studies on a topic. Whilst equipment manu-
facturers appear to have contributed funding to many of the trials
identified, it is difficult to see what the impact of this has been.
For example, whilst bias in favour of positive results cannot be dis-
counted, most of the studies published did not find a statistically
significant difference.
Commonmethodological flaws include lack of allocation conceal-
ment, lack of baseline comparability, high attrition rates, lack of
intention to treat analysis, lack of blind or independently veri-
fied outcome assessment. Specific to pressure ulcer intervention
research, other flaws include failing to report on whether partici-
pants were pressure ulcer free or not on study entry and providing
an adequate definition for pressure ulcer status. These deficiencies
further reduce the confidence with which we can regard many of
the individual study findings. It is however, heartening that the
recently included studies have improved reporting of some study
details to enable quality assessment.
Future trials should continue to address these deficiencies and col-
lect data on aspects of equipment performance such as reliability.
It is hoped that future studies will be reported in line with current
international standards for trial reporting (Moher 2001).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In people at high risk of pressure ulcer development, where possible
higher specification foam mattresses rather than standard hospital
foam mattresses should be used. Organisations should consider
the use of selected pressure relief devices for high risk patients in
the operating theatre, as this is associated with a reduction in post-
operative incidence of pressure ulcers. Medical grade sheepskins
are associated with a decrease in pressure ulcer development. The
relativemerits of higher-tech constant lowpressure and alternating
pressure for prevention are unclear, however alternating pressure
mattresses may be more cost effective than alternating pressure
overlays. Seat cushions have not been adequately evaluated.
Implications for research
Independent, well-designed,multicentreRCTs are needed to com-
pare the clinical and cost-effectiveness of different types of pres-
sure-relieving devices for patients at different levels of risk in a
variety of settings. Particular gaps, include comparisons of:
(a) alternating pressure devices with other ’high-tech’ equipment
(such as low air-loss and air-fluidised beds) for prevention in very
high risk groups
(b) alternating pressure devices with lower tech alternatives (such
as different types of high specification foam mattresses and other
constant low pressure devices).
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The evaluation of alternating pressure devices is given emphasis as
they are viewed as standard preventive interventions in some areas
and not others and may vary widely in cost (from less than £1,000
(UK) to more than £4,000).
Research is needed into valid and reliable methods of detecting
early skin damage that is prognostic of pressure ulcer development,
and of the impact of pressure ulcers on quality of life. Future
research must address the methodological deficiencies associated
with much of the research described in this review.
Patients should be truly randomised (with concealed allocation),
trials should be of sufficient size to detect clinically important dif-
ferences, and have clear criteria for measuring outcomes which
ideally should be assessed without knowledge of the intervention
received (blinded). Interventions under evaluation should be thor-
oughly and clearly described. Researchers should be encouraged
to develop measures to assess patient experiences of pressure-re-
lieving equipment e.g. comfort. The studies should also have ad-
equate follow-up and appropriate statistical analysis. The CON-
SORT statement (Moher 2001) should be used as a guideline for
reporting.
Given the high costs associated with the prevention of pressure
ulcers generally, and of pressure-relieving surfaces specifically, em-
phasis should be given to robust economic evaluations conducted
concurrently with trials.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Andersen 1982
Methods Prevention Trial: RCT with 10 day follow up. Method of allocation unclear
Participants Patients in acute setting at high risk of pressure ulcer development (Andersen scale), and without existing
pressure ulcers
Interventions 1. Standard hospital mattress (161)
2. Alternating air mattress (AP) (166)
3. Water filled mattress (air mattress for camping filled with water) (155)
Outcomes Incidence of pressure ulcers (skin examined on alternate days).
Grade 2 or greater ulcers (broken skin):
Alternating mattress: 4.2% (7/166);
Water mattress: 4.5% (7/155);
Standard mattress: 13.0% (21/161)
Notes 118 out of 600 selected patients dropped out during first 24 hours. A priori sample size calculation.
AP easily punctures and in this study was not always set at optimum pressure. Water bed is heavy and
time-consuming to fill. Patients more satisfied with ordinary bed: complained of the noise and pressure
changes of AP
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Aronovitch 1999
Methods Prevention Trial: 7 days follow-up
Participants 18 years old; free of pressure ulcers; undergoing elective surgery under GA, of at least 3 hours operative
time.No significant differences between groups for age, sex, race, weight, height, smoking status at baseline
but patients in conventional management group were at greater risk of pressure ulcer development as
defined by Knoll score
Interventions 1. AP system intra and postoperatively (Micropulse) (112) Micropulse is thin pad with over 2,500 small
air cells in rows; 50% cells inflated at any time.
2.ConventionalManagement (105)Conventionalmanagement comprised use of a gel pad in the operating
room and a replacement mattress postop
Outcomes 1. MicroPulse system 1% (1/90) however ulcer due to foreign body and considered “not related to the
bed”
2. Conventional Management 9% (7/80) (7 patients developed 11 ulcers) Grade 1: 1
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Aronovitch 1999 (Continued)
Grade 2: 4
Unstageable: 6 P<0.005
Notes 1. MicroPulse system: Device was inadvertently turned off during treatments of 4 patients. 4 patients
asked to withdraw for various unreported reasons. 3 patients withdrew due to back pain. 12 patients
assigned to this group were placed on another surface postop for reasons unrelated to the surface.
2. Conventional Management Group: 6 patients were placed on the MicroPulse postop. Analysis was on
an intention-to-treat basis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Bennett 1998
Methods Prevention Trial: Follow up 60 days.
Median length of follow up (days):
1. 4 (1-60)
2. 6 (1-62) P<0.017
Participants Acute and long term care patients who were incontinent of urine and/or faeces, in bed >16 hours per
day, with pressure ulcers grade 2 or below (or none). If urinary catheter present, this was removed in the
LAL group (not control group). Most common diagnoses: sepsis; malignancy; fractured neck of femur;
hypovolaemia; dementia
Interventions 1. Low Air Loss Hydrotherapy (LAL Hydro) (42) Clensicair (SSI/Hill Rom). Permeable fast drying filter
sheet over low air loss cushions (circulating air). Urine collection device integral to bed
2. Standard care (56) Standard care comprised standard bed or foam, air, alternating pressure mattresses.
Skin care not standardised
Outcomes Number of patients who developed any kind of skin lesion more than 1 day after enrolment:
1.27/42 (64%)
2.10/56 (18%)
Number of patients who developed pressure ulcers Grade 2-4:
1.8/42 (19%)
2.4/56 (7%) P=0.11; NS
Number of patients with non-blanchable erythema (Grade 1):
1. 6/42 (14%)
2. 0/56 P=0.008
Only 26 ulcers present on enrolment, and only 3 of these were Grade 3 or 4 so no healing data presented
Notes The first 68 patients were discounted and a further 26 patients of 116 withdrew. No intention to treat
analysis. Nurses received special extra training for the LAL bed. LAL patients were interviewed about
satisfaction, control patients were not. There were many nurse complaints about the LAL; firmly held
belief that it was associated with more ulceration. Two subjects in the LAL group developed hypothermia.
Findings may not relate to subsequent products since developed
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Bennett 1998 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Cadue 2008
Methods Prevention RCT with maximum follow-up 30 days.
Participants Patients in an intensive care setting without exiting a pressure ulcer deemed at high risk (Waterlow Score
>10) and aged 18 year or over. Participants seemed generally matched at baseline
Interventions 1. Foam body support and standard pressure prevention protocol (half seated position, water mattress
preventative massage 6 times a day)(35).
2. Standard pressure ulcer protocol (as above)(35).
Outcomes Number of participants developing non-blanching pressure ulcer or worse on the heel:
1. Foam body support 8.6% 3/35
2. Usual care 55.4% 19/35
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear: Envelope but further details not known
Cavicchioli 2007
Methods Prevention RCT: Follow-up of 2 weeks
Participants Acute and long-term care participants deemed at risk of pressure ulceration (Braden score <17 activity
or mobility sub-scales <3 respectively). Patients had an expected admission of at least 2 weeks. Patients
could have one grade 1 pressure ulcer at baseline but were excluded if they had more than one pressure
ulcer; or their pressure ulcer was grade 2 or above. Baseline balance for age, sex and Braden score in the
randomised groups
Interventions 1. High-tech (Duo 2, Hill Rom) mattress on alternating low pressure setting (86).
2. High-tech (Duo 2, Hill Rom) mattress on continuous low pressure setting (84)
Outcomes Number of participants with Incidence pressure ulcer (blinded outcome assessment at study end):
Grade 1
1. Alternating low pressure 1/69
2. Continuous low pressure 0
Grade 2
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Cavicchioli 2007 (Continued)
1. Alternating low pressure 1/69
2. Continuous low pressure 1/71
Notes This was a three armed study. There was a two armed RCT as described and a controlled group (standard
mattress), not formed by randomisation and not included here
Blinded outcome assessment ws conducted for the randomised groups
Follow up figures were:
1. 69 (four deaths, 8 participants discharged before final assessment, and five classed as not having
completed the study due to non-concordance);
2. 71 (5 deaths, four discharged and 4 classed as non-concordant). Not ITT
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear no details provided
Cobb 1997
Methods Prevention RCT: 40 days follow-up
Participants Recruitment took place in hospital wards and intensive care units. Participant had to be over 18 years of
age, weigh 290 pounds or less, not have a pre-existing pressure ulcer, an expected length of stay of one to
two weeks and be at “high risk” based on the Braden Scale. Patients were allocated through the selection
of a treatment card by an independent nurse. There was some baseline imbalance observed with older
participants and more participants with co-morbidities in the KinAir group
Interventions 1. Low loss air bed (KinAir Bed) (62)
2. Static air mattress overlay (EHOB waffle) (61)
Outcomes Number of participants with Incidence pressure ulcer (ICU participants assessed daily, ward patients
assessed every 48 hours):
Grade 1
1. KinAir Bed 3/62
2. EHOB waffle 1/61
Grade 2.
1. KinAir Bed 3/62
2. EHOB waffle 11/61
Eschar
1. KinAir Bed 2/62
2. EHOB waffle 0/61
Notes No higher grades reported. Not loss to follow up reported.
Risk of bias
Item Authors’ judgement Description
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Cobb 1997 (Continued)
Allocation concealment? Yes A - The use of an independent nurse picking a treatment card
Collier 1996
Methods Prevention Trial: RCT comparing 8 different foam mattresses; length of follow up not clear but patients
assessed weekly. Allocation as follows: mattresses assigned to beds and coded numerically with only the
principal investigator and ward link nurse aware of identity of each mattress. Mattresses then allocated to
patients “as available”
Participants Patients on a general medical ward; no further detail given
Interventions Comparison of 8 foam mattresses:
1. New Standard Hospital Mattress (Relyon) (130 mm) (9)
2. Clinifloat (11)
3. Omnifoam (11)
4. Softform (12)
5. STM5 (10)
6. Therarest (13)
7. Transfoam (10)
8. Vapourlux (14)
Outcomes Incidence of pressure ulcers. Patients were assessed at least weekly throughout the hospital stay. No patient
developed a pressure ulcer of any grade during whole study
Notes 9 patients were allocated the Cyclone mattress however this group was withdrawn from the study at
manufacturer’s request and data not presented. All mattresses assessed for “grounding”, deterioration of
cover and contamination of inner foam core, interface pressures. No “grounding” of any mattresses during
the evaluation period; softening of the centre of the foam base in Standard and Omnifoam mattress on
completion of study (detected using a “fist test” of unknown reliability). All mattress covers remained
intact and inner foam protected
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Conine 1990
Methods Prevention Trial: Sequential RCT with 3 month follow up. Method of allocation unclear
Participants Patients with chronic neurological diseases aged 18-55 years with no evidence of skin breakdown for at
least 2 weeks prior to the study. Patients in the 2 groups were well matched at baseline for key variables e.g.
Norton score; sex; age; underweight/overweight; diagnoses; years as a wheelchair user; history of previous
pressure ulcers; incontinence. Setting extended care facility for chronic neurological conditions
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Conine 1990 (Continued)
Interventions 1. Alternating pressure overlay (72)
10 cm air cells. Cycle time not stated, nor the make of overlay
2. Silicore (Spenco) overlay (76)
siliconised hollow fibres in waterproofed cotton placed over standard hospital mattress (spring or foam).
All patients received usual care including 2-3 hourly turning; daily bed baths; weekly bath/shower; use of
heel, ankle and other protectors
Outcomes Incidence of pressure ulcers (including Grade 1). Pressure ulcer status was checked by another researcher
blind to the study. Inter-rater reliability high.
Included grade 1 ulcers:
1. Alternating air overlay: 54% (39/72)
2. Spenco overlay: 59% (45/76)
The alternating air overlay group had a slightly lower than average ’Exton-Smith severity score’ (1.59 vs
1.69); a shorter than average healing duration (25 days vs 29 days), not statistically significant
Notes Alternating air overlay needed frequent monitoring and expensive prolonged repairs. It was reported that
the patients sank into the Silicore overlay and found it difficult to move. Patients complained of bad odour
build-up, instability (especially Silicore), and noise of the alternating pressure motor. High dropout rate
due to discomfort
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Conine 1993
Methods Prevention trial with 3 month follow up
Participants Extended care patients > 60 years; free of skin breakdown for at least 2 weeks prior to study; considered
to be at high risk of pressure ulcers; sitting in wheelchair for a minimum of 4 consecutive hours; free of
any progressive disease which could lead to bed confinement
Interventions 1. Slab cushion bevelled at base to prevent seat sling (144)
2. Contoured foam cushion with a posterior cut out in the area of ischial tuberosities and an anterior
ischial bar (144)
Outcomes 1. Slab cushion 85/125 (68%)
2. Contoured foam cushion 84/123 (68%)
Notes No intention to treat analysis
Risk of bias
Item Authors’ judgement Description
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Conine 1993 (Continued)
Allocation concealment? Unclear B - unclear
Conine 1994
Methods Prevention Trial: RCT of two wheelchair cushions with 3 month follow up. Method of randomisation
unclear as patients were described as “randomly allocated by the principal investigator”
Participants Elderly patients (mean age 82 yrs) in an extended care hospital deemed at high risk of pressure ulcers
(Norton Score of 14 or less); sitting in a wheelchair daily for minimum of 4 consecutive hours; free of
progressive disease likely to confine them to bed. Excluded if diabetic, had peripheral vascular disease;
confined to bed for more than 120 consecutive hours (except if to heal a pressure ulcer).
There were no statistically significant differences between groups at baseline for Norton scores; age; hours
in bed/day; sex; diagnosis; sensory loss; history of previous ulcers; weight; nutritional status; oedema;
incontinence; hours in wheelchair/day
Interventions 1. Jay cushion (68)
The Jay cushion is a contoured urethane foam base over gel pad
2. Foam cushion (73)
30kg per cubic metre density foam bevelled at the bottom to prevent sling effect
Both cushions fitted with identical Jay air-exchange covers of knitted polyester. Patients were assigned to
their specific wheelchairs by a seating specialist as per a local policy unaffected by the trial
Outcomes 1. Jay Cushion 17/68 (25%)
2. Foam Cushion 30/73 (41%)
Pressure ulcer incidence data is presented as number of ulcers and number of affected patients for all
grades of ulcer, but only as number of ulcers by Grade (and there were cases of multiple ulcers on the same
patient). Therefore it is impossible to present the incidence data as number of patients affected by ulcers
of Grade 2 or above
Notes 13% attrition; not analysed by intention to treat
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Cooper 1998
Methods Prevention Trial: RCT with 7 day follow up. Allocation by consecutively numbered, sealed, opaque
envelopes
Participants 100 patients aged over 65 years, with no pressure ulcers, from three 24 bedded mixed emergency or-
thopaedic trauma wards. All patients at risk of pressure ulcers with Waterlow Risk scores of 15 and above.
Baseline variables similar for each group (age, sex, mobility, Waterlow scores)
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Cooper 1998 (Continued)
Interventions 1. Dry flotation mattress (Roho) (49) [Data supplied for only 43]
2. Dry flotation mattress (Sofflex) (51) [Data supplied for only 41]
Outcomes Grade 2 and above: 1. Roho mattress: 2. Sofflex mattress: 1/51 (2%)
Grade 1 ulcers: 1. Roho mattress: 5/43 (12%) 2. Sofflex mattress 2/41 (5%)
Notes Roho mattress: 79% patients found it comfortable or very comfortable 5 found it uncomfortable. Sofflex
mattress: 90% patients found it comfortable or very comfortable. Staff had difficulty setting the level of
inflation correctly; this can now be done automatically. 16% attrition; no intention to treat analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Daechsel 1985
Methods Prevention Trial: RCT with 3 month follow up. Method of allocation unclear
Participants 32 patients with chronic neurological conditions in a long term care hospital. All aged between 19 and
60 years, free from skin breakdown on entry, considered at high risk of pressure ulcers
Interventions 1. Alternating pressure mattress (Gaymar Inc)(16)
2. Silicore overlay (JW Westman Inc)(16)
Outcomes Included grade 1 ulcers:
1. Alternating overlay: 25% (4/16)
2. Spenco overlay: 25% (4/16)
No statistically significant differences were found between the two groups with regard to location and
severity of pressure ulcers
Notes 100% follow up. Patients’ satisfaction was similar for both devices
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Economides 1995
Methods Prevention Trial: RCT with 2 week follow up. Allocation by sealed envelope
Participants 12 patients who had stage 4 pressure sores needing myocutaneous flap closure. 10 out of 12 participants
were paraplegic or quadriplegic. Groups appear broadly comparable at baseline except the ROHO group
seem to have slightly better nutritional status (not tested for significance)
Interventions 1. Roho dry flotation mattress (6)
Bed overlay consisting of 720 air cells that conform to the body to provide maximum support area and a
“floating” environment
2. Air-fluidised Clinitron bed (6)
Ceramic microspheres through which warm pressurised air is blown, covered by a polyester sheet. The
bed forms a dry-fluid environment on which the patient floats so distributing body weight away from
bony prominences
Outcomes Wound breakdown: 2/6 on Roho vs 2/5 on Clinitron. No significant difference between two support
surfaces in the prevention of flap breakdown in the immediate post-operative period
Notes Do not appear to have had any withdrawals
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Ewing 1964
Methods Prevention and Treatment Trial: RCT with 6 months follow up. Mode of allocation unclear - stated as
random selection
Participants Elderly patients, average age 72.5 years, confined to bed, with reducedmobility in the legs due to neurolog-
ical disorder, or fixed joints, peripheral vascular disease. No baseline data given and baseline comparability
not described. Setting is the geriatric unit of a convalescent hospital
Interventions 1. The sheepskins were adjusted so that both legs were supported on the woolly fleece (18)
2. Control, without sheepskins (18) All were submitted to the same 4-hourly routine skin care involving
washing, drying, powdering, light massage of pressure areas, bed cradle
Outcomes The study was too small and poorly designed to detect a difference. No reports of withdrawals
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Exton-Smith 1982
Methods Prevention Trial: RCT with 2 week follow up. Allocation by alternation and where the surface of choice
was not available the patient was given an available surface
Participants Newly-admitted geriatric patients, with fractured neck of femur, and long-stay patients; without pressure
sores of grade 2 or greater. Norton score <14 Patients were matched in pairs for sex and Norton score.
Where a match was not possible, the Airwave patient was matched with a Large Cell Ripple patient with
a higher risk score. Groups appear well matched at baseline
Interventions 1. Pegasus Airwave system (31) 2 layers of air cells; pressure alternated by deflating every 3rd cell in a 7.5
minute cycle. The mattress is ventilated with pinholes through which air passes to keep the patient’s skin
dry
2. Large Cell Ripple Mattress (31)
Large cell ripple not described
Outcomes Grade 2 ulcer or greater
1. Airwave (AWS): 16% (5/31)
2. Large Cell Ripple (LCR): 39% (12/31)
Notes During the trial period, no breakdowns with AWS, 10 breakdowns on LCR, 4 patients withdrawn; 94%
follow up
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Feuchtinger 2006
Methods Prevention RCT: 5-day follow-up (post-operative)
Participants Recruitment took place in a Department of Cardionvascular Surgery. Eligible patients were aged 18 years
or over, schduled for cardiac surgery with extracorporal circulation. They did not have to be pressure ulcer
free and four patients had grade 1 pressure ulcers as they went into surgery. Participants were well matched
at baseline
Interventions 1. Operating table with waterfilled warming mattress and a 4cm thermoactive viscoelastic foam overlay.
(85)
2. Standard OR table configuration (OR table with waterfilled warming mattress). (90)
Outcomes Number of participants with incidence pressure ulcer (assessed day 1, 3 and 5 post-operatively; blinded
outcome assessment):
Grade 1; Post op day 0-5
1. Thermo 15.3% (13/85)
2. Standard 10% (9/90)
Grade 2; Post-op day 0-5
1. Thermo 2.4% (2/85)
2. Standard 1% (1/90)
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Feuchtinger 2006 (Continued)
Notes No higher grades reported. No participant loss reported. The study was stopped after interim analysis due
to the 11.1% total incidence in the standard group vs. 17.6% in the treatment group
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear no details provided
Gebhardt 1994
Methods Prevention Trial: Allocation by case sheet number
Follow up mean 16 days
Participants Newly admitted patients aged over 18 years with Norton score <14 and without existing ulcers. Patients
in ICU, oncology, medical, care of the elderly, orthopaedic wards. Groups well matched at baseline for
age, Norton score, sex
Interventions 1. Alternating pressure air mattresses [various] (115)
2. Constant low pressure (foam, fibrefill, air, water, gel) supports [various] (115) Patients with deteriorated
ulcers were transferred to more sophisticated medium cost support in the same group (e.g., Pegasus,
Nimbus, Orthoderm, Convertible, Roho)
Outcomes Grade 2 or greater ulcer:
1. Alternating pressure: 16% (18/115)
2. Constant low pressure: 55% (63/115)
Notes Analysis by intention to treat. Mechanical unreliability and poor management of alternating pressure
supports was a problem
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Gentilello 1988
Methods Prevention Trial: RCT thoughmethod of allocation unclear. Duration of follow up unclear. Trial primarily
not a pressure sore trial; kinetic treatment tables used to prevent chest infection in immobile patients
Participants Critically ill patients in surgical ICU immobilised because of head injury, spinal injuries or traction.
Groups well matched at baseline for demographic and pulmonary risk factors; patients in the conventional
bed group had higher incidence of cigarette smoking
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Gentilello 1988 (Continued)
Interventions 1. Kinetic Treatment Table (27)
Rotates through an arc of 124 degrees every 7 minutes. Nurses were instructed to leave the bed rotating
except when vital signs being recorded and treatments given. If a patient developed a serious complication
as result of KTT, they were moved onto conventional bed
2. Conventional beds (38)
Patients turned in conventional fashion every 2 hours. If a patient in this group developed a chest infection
and positioning thought to be a factor the patient was moved onto a KTT
Outcomes Primary outcomes were:
Incidence of pulmonary complications
Other outcomes measured included Incidence of pressure ulcers
Kinetic Treatment Table 30%
Conventional: 26%
Notes 1 patient withdrew and was not included in the analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Geyer 2001
Methods Pilot Prevention RCT: 12 months follow-up
Participants Recruitment of wheel chair users in (elderly) nursing homes. Eligible patients were users aged 65 years
and over at risk of PU development (Braden score of less than or equal to 18). They also had to have a
combined Barden activity and mobility sub-scale of less than or equal to 5, no pressure ulcers on their
sitting surface and be tolerant of daily wheelchair sitting for 6 hours or more, in the ETAC twin wheelchair
(this required a body weight below 250lbs). Participants were well matched at baseline for age, inital
Braden score, sex
Interventions 1. Pressure-reducing wheel chair cushion. (15) No single make of cushion was specificed, rather this could
be selected by the nurse from a group of cushions based on the participants clinical status. Further details
about cushion design not provided
2. Standard foam (eggerate) cushion (Bioclinic Standard, Sunrise Medical) (17)
Outcomes Number of participants with Incidence pressure ulcer (weekly assessment; blinded outcome assessment):
Grade not reported. All grades
1. Pressure-reducing cushion 40% (6/15)
2. Foam cushion 58.5%(10/17)
Notes Seating assessments were performed in both groups through-out the study.
1. One participant died, three lost to follow-up.
2. One participant died two lost to follow-up.
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Geyer 2001 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate (Sequentially numbered envelopes)
Gilcreast 2005
Methods Prevention RCT of heel ulcers: follow-up period unclear
Participants Recruitment was from military tertiary care academic medical centres. Eligilbe patients were at moderate
or high risk of pressure ulcer development (Braden score equal to or less than 14). Patients with hip
surgery were excluded as were patients anticipated to be admitted for less than 72 hours and those with
pre-existing heel pressure ulcers. Limited baseline information presented. There was baseline imbalance
in sex
Interventions 1. Bunny Boot (fleece) high cushion heel protector
2. Egg crate (holds the foot suspended above the bed surface with heel through a window) heel lift
positioner
3. Foot waffle (felt coated plastic inflatable plastic pillow which encircles the foot) air cushion
Outcomes Pressure ulcer incidence (Does not stratify by grade; baseline numbers not available and not clear if the
unit is number of ulcers or number of patients):
1. Bunny Boot (fleece) 3/77
2. Egg crate 4/87
3. Foot waffle 5/76
Notes 69% of participant were in ICU. Of the initial 338 patients only 240 had follow-up data, given as n in
outcomes. Not clear how the 338 was distributed among the three groups. 53 not included as did not
wear the devices for at least 48 hours; 45 not included as they were non-compliant. Not ITT
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C- Inadequate (non-numbered envelopes)
Goldstone 1982
Methods Prevention Trial: Patients allocated alternately to one of 2 alternative surfaces. Follow up not clear
Participants Patients (>60 years) with femur fracture. (Mean Norton score 13) Groups comparable at baseline for age,
Norton Score
Interventions 1. Beaufort bead bed system which includes bead-filled mattress on A&E trolley; bead-filled operating
table overlay; bead-filled sacral cushion of operating table; bead-filled boots to protect heels on operating
table (32)
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Goldstone 1982 (Continued)
2. Standard supports in A&E, operating theatre, ward (43)
Outcomes Grading of ulcers was not given. Beaufort bed: 16%
Standard surface: 49% Maximum width of broken skin (mean): 6.4 mm on Beaufort beds vs 29.5 mm
on Standard
Notes Patients who were found to be incontinent of urine (numbers not given) and in the Beaufort bead bed
group were catheterised however it does not seem to be the same for the control group.
Patients were removed from Beaufort bed standard surfaces due to unknown reasons. Number of with-
drawals unclear; no intention to treat analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Gray 1994a
Methods Prevention Trial: RCT with 10 day follow up. Allocation by sealed envelope
Participants Patients from orthopaedic trauma, vascular and medical oncology units without breaks in the skin (Wa-
terlow score >15)
Groups well matched at baseline for age, sex, Waterlow score
Interventions 1. Softfoam mattress (90)
2. Standard 130 mm NHS foam mattress (80)
Outcomes Incidence of pressure ulcers. Skin condition assessed at 5 and 10 days; presumably assessor not blind to
treatment group.
Grade 2 or greater ulcer:
Softform: 7%
Standard: 34%
Rate of transfer to dynamic support surface: 19% in standard group vs 2% in Softform group
Notes Impossible to calculate attrition rate as incidence reported as % only and unclear what the denominator
is. Nurses were more positive and patients gave higher comfort scores to Softform mattress
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Gray 1994b
Methods Follow up 10 days
Participants Patients admitted to a District General Hospital for bed rest or surgery, with intact skin, no other skin
abnormalities, no terminal illness, weight <160 kg. Mean Waterlow score on admission: 1. 14 (3.6) 2. 13
(2.5)
Interventions 1. Transfoam mattress (50)
2. Transfoamwave (50) (both foam)
Outcomes 1. 1 Grade IV ulcer
2. 1 Grade II ulcer
Notes 95% follow up; intention to treat analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Gunningberg 2000
Methods Follow up until discharge or 14 days post-op
Participants Patients admitted with a suspected hip fracture via an A&E department who were >65 years and did not
have pressure ulcers
Interventions 1. 10 cm visco-elastic foam mattress on arrival in A&E and visco-elastic foam overlay on standard ward
mattress (48)
2. Standard A&E trolley mattress and ward mattress (53)
Outcomes Grade II-IV incidence: 1. 4/48 (8.3%); 2. 8/53 (15%) Pressure ulcer incidence (all grades) 1. 12/48 (25%)
; 2.17/53 (32%)
Mean comfort rating 1. 4.2; 2.4.0
All results non-significant
Notes Only 44 participants completed the comfort questionnaire
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
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Hampton 1997
Methods Prevention Trial: RCT but method of allocation not described. Duration of follow up to a maximum of
20 days
Participants Very little detail; average age 77 years. No data regarding baseline status of patients presented in the
published paper therefore impossible to judge baseline comparability. Only limited information obtained
on request: Number patients at high-very high risk Airwave Group = 31; Number patients at high-very
high risk Cairwave Group = 27. Mean age A=79 Mean Age C=75
Interventions 1. Alternating pressure (Cairwave System) (36)
3 cell, 7.5 minute cycle. Manufacturers claim that zero pressure achieved for more than 20% of the cycle
2. Alternating pressure (Airwave System) (39)
Cells arranged in sets of 3 and are inflated in waves. 7.5 minute cycle; zero pressure said to be applied for
15% of the time
Outcomes Incidence of pressure ulcers.
No patient in this study developed a pressure ulcer
Notes Attrition unclear
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hofman 1994
Methods Prevention Trial: RCT with 2 week follow up. Patients randomised in blocks of 6 but method of ran-
domisation not described
Participants Patients with a femoral-neck fracture and risk score >8 (Dutch consensus scale). Excluded patients with
pressure ulcers of grade 2 or greater on admission.
Groups were similar at baseline for pressure ulcer risk; haemoglobin; total serum protein and serum
albumin
Interventions 1. Cubed foam mattress (Comfortex DeCube mattress) (21)
Allows removal of small cubes of foam from beneath bony prominences
2. Standard hospital mattress (23)
Standard polypropylene SG40 hospital foam mattress.
Both groups were treated according to the Dutch consensus protocol for the prevention of pressure ulcers
Outcomes Incidence of ulcers of Grade 2 or greater at 2 weeks. Outcome assessment not blind to treatment group.
Patients were examined 1 and 2 weeks after surgery by two independent observers; disagreement resolved
by a 3rd observer.
Grade 2 or greater ulcers: Comfortex DeCube: 24% (4/17); Standard: 68% (13/19) Maximum pressure
ulcer gradings were significantly higher for the standard mattress than the DeCube mattress at 1 and 2
weeks
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Hofman 1994 (Continued)
Notes 78% follow up. No intention to treat analysis. DeCube mattress was not always used correctly and its size
was not optimum for all patients.
A priori sample size calculation
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Inman 1993
Methods Prevention Trial: RCT with an average of 17 days follow up. Method of allocation unclear
Participants Patients aged over 17 years with an Acute Physiology and Chronic Health Evaluation (APACHE II) score
greater than 15 who had an expected intensive care unit stay of >3 days
Interventions 1. Low-air-loss beds (49)
2. Standard ICU bed (49); patients rotated every 2 hours
Outcomes Incidence of pressure ulcers reported in the trial as both ulcers per patient and patients with ulcers. We
have only extracted the incidence of patients developing ulcers.
Grade 2 or greater ulcers: Low-air-loss beds: 12%; Standard ICU bed: 51% Patients with multiple pressure
ulcers: 2% on Low-air-loss beds and 24% on standard ICU bed
Notes A priori sample size calculation. 98/100 patients randomised completed the study (1 lost from each group)
as did not stay in ICU for 3 days; neither developed a sore.
No ITT analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Jolley 2004
Methods Prevention RCT: Unclear follow-up period, mean bed days observed/participant 1. 7 days and 2. 7.9 days
Participants Participants were recruited from a single hospital, and had to be at low to moderate risk of developing
a pressure ulcer and over 18 years of age. Patients were excluded if they had no risk or high risk (more
complex interventions required), if they had any pre-existing ulcers, had an expected length of stay of
less than 48 hours or had darkly pigmented skin (justified by authors as making grade 1 ulcer difficult to
detect)
Participants well matched at baseline for age, sex, mean pressure ulcer risk score
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Jolley 2004 (Continued)
Interventions 1. Sheepskin mattress overlay. This is leather-backed with a dense, uniform 25 mm wool pile. Used as a
partial mattress overlay. Pressure points not covered by sheepskin were protected by a second sheepskin or
specific sheepskin elbow and heel protectors. Overlays were changed three times a week (unless required)
. Received usual care including repositioning. (270)
2.Usual care as determined by ward staff. Includes repositioning and any other PRD or prevention strategy
with/without low-tech constant pressure relieving devices. (269)
Outcomes Number of participants with incidence pressure ulcer (daily assessment; unblinded outcome assessment):
All Ulcers (grade 1 and 2; no grade 3 or 4 recorded)
1. Sheepskin 21/218
2. Usual care 37/223
Total number of incidence ulcers
1. Sheepskin 27
2. Usual care 58
Total number of incident stage 2 ulcers
1. Sheepskin 12
2. Usual care 20
Notes Whilst 270 were allocated to the sheepskin and 269 to control; only 218 and 223 received their allocated
treatment and are included in the analysis. Not ITT
‘Any patient whose risk increased to high (Braden score <12) for 48 hours was no longer followed up
for pressure-ulcer endpoints. Authors do not say why. Of the 218 included participants in the sheepskin
group there were 2 deaths, 7 became high risk (treatment change), 14 requested withdrawal, 6 had ward
staff intervention and 11 changed treatment for other reasons). Of the 223 control participants there
were 5 deaths, 1 became high risk, 8 requested withdrawal, 5 had ward staff intervention and 10 changed
treatments for other reasons
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate (numbered cards in opaque envelopes)
Kemp 1993
Methods Prevention Trial: RCT with 1 month follow up. Allocation by random number table
Participants Inclusion criteria were: aged over 65 years, inpatients, with a Braden Score of 16 or less. Age ranged from
65-98, 58 women, 26 men. Recruited from general medicine, acute geriatric medicine and long term care.
All patients free from pressure ulcers on admission.
Groups similar for important variables at baseline
Interventions 1. Convoluted foam overlay, 3 or 4 inches thick (45)
2. Solid foam overlay 4 inches thick, sculptured (39)
Outcomes Incidence of pressure ulcers assessed by Research Nurse presumably not blind to intervention.
Included grade 1 ulcers:
Convoluted foam overlay: 47%;
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Kemp 1993 (Continued)
Solid foam overlay: 31%
Notes All patients appear to have completed the study
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Keogh 2001
Methods Follow up 5-10 days
Participants Patients from two surgical and two medical wards who were: >18 years; Waterlow score of 15-25; tissue
damage no greater than grade 1
Interventions 1. Profiling bed with a pressure reducing foam mattress/cushion (50)
2. Flat-based bed with a pressure relieving/redistributing mattress/cushion (50)
Outcomes 1. 0/35
2. 0/35
Healing of existing grade 1 ulcers
1.4/4
2.2/10
Notes The extent of follow-up difficult to ascertain. No difference between the groups in terms of transferring
in and out of bed
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Laurent 1997
Methods Prevention Trial: RCT with factorial design. Two pressure relieving mattresses used either in ICU (alter-
nating pressure), or in post-ICU hospitalisation (constant low pressure), or in combination and compared
in each case with the standard surface. Randomised “by blocks” - method of allocation unclear
Participants Adults over 15 years of age, admitted for major cardiovascular surgery, hospital stay likely to be at least 5
days, with a period on ICU.
Little data provided regarding baseline comparability
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Laurent 1997 (Continued)
Interventions 2 X 2 Factorial Design:
1: Standard Mattress ICU; Standard Mattress Postop (80)
2: Nimbus (AP) ICU; Standard Mattress Postop (80)
3: Standard Mattress ICU; Tempur (CLP) Postop (75)
4: Nimbus ICU; Tempur Postop (77)
Outcomes Incidence of ulcers of Grade 2 or above (partial or full thickness skin loss and worse):
Group 1: 18% (14/80);
Group 2: 13% (10/80);
Group 3: 15% (11/75);
Group 4: 13% (10/77) NS
Notes A priori sample size calculation.
No reports of withdrawals
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Lazzara 1991
Methods Prevention and Treatment Trial: RCT (allocation by random number tables) in elderly nursing home
population with 6 month follow up
Participants Nursing home residents at risk (Norton score greater than 15) of pressure ulcers. 9 out of the total 66
subjects had pressure ulcers on entry to the study
Interventions 1. Air filled (SofCare) overlay (33 randomised; 2 ulcer on admission; 10/31 developed a new one).
2. Gel mattress (33 randomised; 7 ulcer on admission; 8/26 developed a new one)
Outcomes Grade 2 or greater ulcers:
1. Air overlay: 16% (5/31)
2. Gel mattress: 15% (4/26)
Notes Interventions not well described. Of the 74 who entered the study, only those who participated for 4-6
months were included in the analysis (total of 66). 19 patients died and were excluded from the analysis
but these might be at highest risk. It was difficult to maintain inflation of the air overlay: it also punctured
easily. During the trial, 110 air overlays were used for 76 patients. Gel mattress was heavy
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
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Lim 1988
Methods Prevention Trial: RCT with 5 month follow up. Patients were “randomly assigned” but method of alloca-
tion not described
Participants 62 residents of an extended care facility; aged 60 or over; free of pressure ulcers; at high risk of developing a
sore (Norton score 14 or less); using a wheelchair for 3 or more hours per day; without progressive disease
or confined to bed.
Groups well matched at baseline for sex, age, weight, Norton Score, Primary diagnosis, sensory status,
time spent in wheelchair, mobility
Interventions 1. Foam slab cushion (2.5 cm medium density foam glued to 5 cm firm chipped foam) (26)
2. Contoured foam cushion (same foam as above; cut into a customised shape to relieve pressure on ischial
tuberosities) (26)
Both cushions fitted with identical snug fitting covers of knitted polyester
Outcomes Included grade 1 ulcers:
1. Slab foam: 73% (19/26);
2. Contoured foam: 69% (18/26)
Mean severity score was 1.9 in the slab and 1.7 in the contoured (P>0.05), and the mean healing duration
was 6.2 weeks in the slab and 5.4 weeks in the contoured group (P>0.05)
Notes 84% follow up.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
McGowan 2000
Methods Prevention Trial:
Discharge from hospital, transfer to a rehab ward
Participants Orthopaedic patients aged 60 or over; assessed at low or moderate risk of pressure ulcer development by
Braden scale; intact skin; anticipated LOS greater than 48 hours
Interventions 1. Standard hospital mattress, sheet and an Australian Medical Sheepskin overlay; sheepskin heel and
elbow protectors as required (155)
2. Standard hospital mattress, sheet with or without other low tech constant pressure devices as required
(142) Sheepskins were changed as required (at least every 3 days)
Outcomes 1. Sheepskin Group 14/155 (9%) (21 ulcers) 7 developed 1 ulcer; 7 developed 2. None more severe than
stage I.
2. Control Group 43/142 (30%) (67 ulcers) 25 developed 1 ulcer; 7 developed 2; 11 three. 4 ulcers
were stage II, 1 stage IV. Comfort was rated significantly greater in experimental group. Limb protectors
difficult to keep in place
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McGowan 2000 (Continued)
Notes One patient from each group withdrew prior to data collection. 6 patients in experimental group withdrew
because sheepskin to hot or irritable; 7 in the control group withdrew plus 3 in experimental group due
to protocol violations (no intention to treat). Patients in experimental group rated comfort significantly
higher than controls (P=<0.0001)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Nixon 1998
Methods Prevention Trial: RCT with 8 day follow up. Telephone randomisation (i.e. full allocation concealment)
stratified by centre, and age
Participants Patients aged 55 years and over, admitted for elective major general, gynaecological or vascular surgery in
supine or lithotomy position and free of pre-op pressure damage greater than Grade 1.
Groups well matched at baseline for age, sex, Braden score, type of surgery, duration of surgery, length of
preop stay, proportion of time hypotensive during surgery
Interventions 1. Dry visco-elastic polymer pad on operating table (222)
2. Standard operating theatre table mattress plus Gamgee heel support (224)
Outcomes Incidence and severity of pressure ulcers:
Overall incidence of pressure ulcers of 16% (65/416)
1. Dry visco-elastic polymer pad on operating table 11% (22/205)
2. Standard mattress 20% (43/211) P=0.01 OR=0.46, 95% CI 0.26-0.82.
56/65 episodes of skin damage were conversions from Grade 0 to Grade 1 ulcers.
4/65 Grade 0 to Grade 2a conversions.
5/65 Grade 0 to Grade 2b conversions. This data is not broken down by group
Notes A priori sample size calculation. 133 paired assessments by 94 nurses for pre-study interrater reliability
assessments were undertaken. There was disagreement in only 2.2% assessments and only 2 disagreements
related to differentiating between Grade 1 and Grade 2a ulcers (the remainder were Grade 0 and Grade
1). The majority were associated with heel assessments. In the recovery and ward area assessments, there
were discrepant assessments in only 8.5% cases and sensitivity analysis assessing the impact of this level
of misclassification on the overall result determined that the overall difference between the mattresses
remains.
Main endpoint data reported for 416 patients; incomplete data for 30 patients (lost forms 3; incomplete
postop skin assessment 27). The patients with incomplete data were not reported by group
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Nixon 2006
Methods Prevention RCT: 30 day follow up twice weekly and a further 30 day follow up once weekly
Participants Recruitment took place in 11 hosiptals. Patients admitted as acute or elective cases. Eligible patients were
aged 55 or over, had expected length of stay of at least 7 days and either limitation of activity and mobility
(Braden scale activity and mobility score of 1 or 2) or an existing pressure ulcer of grade 2. Elective surgical
without limited avitivty or mobilty were eligible if the mean length of stay for their surgery was at least 7
days and they were expected to have Braden scale activity and mobility scores of 1 or 2 for at least 3 days
post-operatively. Patients were not eligible if they had a grade 3 or worse pressure ulcer on admission, had
a planned admission to ICU after surgery, were admitted to hospital more than 4 days before surgery,
slept at night in a chair, weighted more than 140kgs or less than 45 kgs (as per mattress specifications)
Participants were well matched at baseline
Interventions 1. Alternating pressure overlay (990)
Alternating cell height min 8.5, max 12.25; cell cycle time 7.5-30, cell cycle 1 in 2, 1 in 3 or 1 in 4
2. Alternating pressure mattress (982)
Alternating cell height min 19.6, max 29.4; cell cycle time 7.5-30, cell cycle 1 in 2, 1 in 3 or 1 in 4
Alternating pressure mattress within 24 hrs of admission (larger cells than for overlay)
Outcomes Number of participants with incidence pressure ulcer grade 2 and above (unblinded outcome assessment)
1. Overlay 10.7% 106/989
2. Mattress 10.3% 101/982
Patient acceptability: requests for mattress change
1. Overlay 23.3% 230/989
2. Mattress 18.9% 186/982
Healing of existing pressure ulcers
1. Overlay 34% 20/59
2. Mattress 35% 19/54
Cost of treatment (£ sterling)
1. Overlay 6793.33
2. Mattress 6509.73
Mean difference in time to pressure ulcer (grade 2 or higher) developement (days)
Participants in mattress group took 10.64 days longer to develop pressure ulcer than overaly group
Notes 1 participant was recruited to the trial twice (group 1) and was excluced from analysis. Factors that has a
significant effect on the proportion of people developing a new pressure ulcer were admission for an acute
condition, the presence of a wound skin trauma or non-blanching erythema on any site at baseline, age,
haemoglobin level and diabetes
The authors state that differences in health benefits and total costs for hospital stay between alternating
pressure mattresses and alternating pressure overlays were not statistically significant. However, a cost
effectiveness acceptability curve indicated that on average, alternating pressure mattresses compared with
alternating pressure overlays were associated with an 80% probability of being cost saving
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Price 1999
Methods Follow up 14 days postoperatively
Participants Patients with fractured neck of femur and Medley score of greater than 25 (very high risk), aged over 60
years
Interventions 1. Repose system (low pressure inflatable mattress and cushion in polyurethane material) (40)
2.Nimbus III dynamic flotation plus TransCell cushion (40) All other care standard best practice including
regular repositioning
Outcomes Blister + Grade II:
1. At admission 1 + 1/40; preoperatively, 1 + 0/36;
at 7 days, 2 + 1/32;
at 14 days, 0 + 3/24
2. At admission, 0 + 2/40; preoperatively, 1 + 3/37;
at 7 days 1 + 0/31,
at 14 days, 1 + 1/26
Notes 80 patients were randomised; 50 in the final analysis i.e.. 38% attrition
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Russell 2000
Methods Prevention Trial: RCT with 7 day follow up. Randomisation using sealed opaque envelope
Participants Patients aged at least 18 years; undergoing scheduled cardiothoracic surgery under GA; surgery of at least
4 hours duration; free of pressure ulcers.
Both groups comparable at baseline for pressure ulcer risk (modified Knoll); history of previous ulceration;
disease status; sex; age; weight; height
Interventions 1. MicroPulse System in the OR and post op (98)
2. Conventional care (gel pad in OR, standard mattress post op) (100)
Outcomes Incidence and severity of pressure ulcers:
1. MicroPulse System 2%* (2/98)2. Conventional Management 7% (7/100 patients developed 10 ulcers)
Grade of Ulcers:1. MicroPulse: Grade 2: 22. Conventional: Grade 1: 2 Grade 2: 5 Grade 3: 3*1/2
discounted by original authors from their analysis as thought to occur for reasons “not related to the use
of the MicroPulse system”!
Notes No equipment-related adverse events were reported
Risk of bias
Item Authors’ judgement Description
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Russell 2000 (Continued)
Allocation concealment? Yes A - Adequate
Russell 2002
Methods Median days in study presented by group by hospital. For the expt group median days ranged from: 8-
14; control group 9-17.
Central allocation at trials office/pharmacy, sequentially numbered or coded vials
Participants Elderly acute, orthopaedic and rehabilitation wards; > 65 years; Waterlow of 15-20
Interventions 1. Visco-polymer energy absorbing foam mattress (CONFOR-Med)/cushion combination (562)
2. Standard mattress/cushion combination (604)
Outcomes Development of non-blanching erythema or worse (including with and without blanching erythema on
admission to trial)
1. 110/562 (19.9%)
2. 161/604 (26.3%) P=0.005 Development of non-blanching erythema or worse
1. 48/562 (8.5%)
2. 66/604 (10.9%) Non-significant
Data for ulcers of Grade >1 not presented separately
Notes Patient comfort scores non significant. NO adverse events reported
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Sanada 2003
Methods Prevention RCT: duration of follow-up not stated
Participants Recruitment was from a single acute care unit. Eligile patients had a Braden score of less than or equal to
16, were bed bound, were pressure free before the start of the study and required head elevation. Exclusion
criteria not discussed. Baseline variables were generally balanced
Interventions 1. Double-layer air cell overlay (Tricell) (37)
2. Single-layer air cell overlay (Air doctor) (36)
Both consisted of multiple air cells where the pressure was alternated between cells at 5 minute intervals.
The two cell overlay has two layers consisting of 24 narrow cylinder air cells. The one cell overlay is one
layer and has 20 round air cells
3. Standard hospital mattress (Paracare) (35)
All groups had change of body position every 2 hours and special skin care to guard against friction and
sheer. Nutritional intervention was given where required
45Support surfaces for pressure ulcer prevention (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sanada 2003 (Continued)
Outcomes Number of participants with incidence pressure ulcer (daily assessment). All ulcers were grade 1 or 2:
Grade 1
1. Double 0/26
2. Single 1/29
3. Standard 4/27
Grade 2
1. Double 1/26
2. Single 4/29
3. Standard 6/27
Notes Number included in study analysis were 1. 26 (2 discontinued, 2 deaths, 7 head elevation equal to or less
than 30 degrees); 29 ( 1 mattress malfunction, 2 deaths, 2 head elevation equal to or less than 30 degrees)
3. 27 (1 death, 7 head elevation equal to or less than 30 degrees). Not ITT
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate (sequentially numbered envelopes)
Santy 1994
Methods Prevention Trial: RCT with 14 day follow up. Allocation by random number tables; degree of allocation
concealment unclear
Participants Patients aged over 55 years with hip fracture with or without pressure ulcers. Excluded: those with a
pressure ulcer of grade 3 or 4 at entry.
Patients in each group well matched for age and Waterlow Score at baseline
Interventions 1. Clinifloat (87)
Deep cut foam cubes in 3 sections with loose fitting cover
2. NHS contract (150 mm) (64)
Single block of high resilience foam. Zipped cover of PVC nylon
3. Vaperm (116)
Made from 4 layers of foam of varying density with holes for ventilation. Profiled heel and head sections
and 2 part cover
4. Therarest (136)
3 layers of foam; extra soft top layer; middle layer claimed to absorb and disperse pressure; bottom layer
prevents bottoming out
5. Transfoam (102)
150 mm thick layered foam with zipped cover of vapour permeable 2-way stretch material. Very high
density foam used with firm central core and firmed edge
Outcomes Rates of removal from study due to skin deterioration:
Clinifloat 9%
NHS contract 27%
Transfoam 10%
Therarest 11%
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Santy 1994 (Continued)
Vaperm 8%
Notes 9% attrition. At interim analysis, Clinifloat and NHS Contract mattresses were removed from the study;
Clinifloat due to superior performance and the NHS mattress due to high rates of pressure sore devel-
opment. This explains why fewer patients on these surfaces. Omnifoam mattress showed foam collapse
after six weeks and were withdrawn from use and replaced with Vaperm mattresses. Problems with mat-
tress cover found on two Therarest mattresses, three Transfoam mattress covers, and three times with the
Clinifloat mattress
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Schultz 1999
Methods Follow up 6 days
Participants Patients admitted for surgery lasting at least 2 hours in lithotomy position, aged 18 or over; admitted with
intact skin
Interventions 1. Experimental mattress overlay in OR made of foam with a 25% ILD of 30 pounds and density of 1.3
(206)
2. Usual care (padding as required, including gel pads, foam mattresses, donuts etc) (207)
Outcomes 1. Experimental OR mattress overlay 55/206 (27%) 6 people had ulcers of Stage II or more
2. Usual care 34/207 (16%) 3 people had ulcers of Stage II or more.
Total number of ulcers = 13915/139 ulcers
Grade II or more severe (11%) p=0.0111
Notes Experimental product caused post-operative skin changes. Authors contacted formore information relating
to grade of ulcer by group
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Sideranko 1992
Methods Prevention Trial: RCT with mean follow up of 9.4 days. Method of randomisation not stated though said
to be ”random“
Participants Adult, surgical intensive care unit patients: SICU stay >48 hr, without existing skin breakdown on ad-
mission. Groups broadly similar at baseline although water mattress group appear to be heavier and with
shorter number of days in ICU (significance of these differences unclear)
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Sideranko 1992 (Continued)
Interventions 1. Alternating air overlay - 1.5” thick Lapidus Airfloat System (20)
2. Static air mattress - 4“ thick Gay Mar Sof Care (20)
3. Water mattress - 4” thick Lotus PXM 3666 (17)
Outcomes Grade of ulcers not reported.
1. Alternating air mattress: 25% (5/20)
2. Static air mattress: 5% (1/20)
3. Water mattress: 12% (2/17)
Notes The trial is primarily about interface pressure and patient position, therefore there is relatively little detail
about the incidence part of the study and no description of co-interventions.
No withdrawals reported
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Stapleton 1986
Methods Prevention Trial: Method of allocation - alternation. Duration of follow up unclear
Participants Female elderly patients with fractured neck of femur without existing pressure ulcers, Norton score 14 or
less. Baseline data presented and groups well matched for age and Norton score
Interventions 1. Large Cell Ripple (Talley) (32)
2. Polyether foam pad 2 ft x ft x 3 inch thickness (34)
3. Spenco pad (34)
Outcomes Ulcers of Grade 2 or greater:
1. Large Cell Ripple: 34% (11/32);
2. Polyether foam pad: 41% (14/34);
3. Spenco pad: 35% (12/34)
Grade 3 and greater:
1. Large Cell Ripple: 0%;
2. Foam pad: 24%;
3. Spenco pad: 6%
Notes 45 Large Cell Ripple mattresses required 50 motor repairs and 90 material repairs during 12 month study.
Patients did not like the feel of the ripples. No mention of withdrawals
Risk of bias
Item Authors’ judgement Description
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Stapleton 1986 (Continued)
Allocation concealment? No C - Inadequate
Summer 1989
Methods Prevention Trial: RCT - duration of follow up unclear. Randomisation by random sequences of letters
corresponding to treatment groups however level of concealment unclear
Participants Patients admitted to the Intensive Care Unit in diagnostic groups: sepsis-sepsis syndrome/pneumonia;
respiratory. failure; drug overdose;metabolic coma; stroke/neuromuscular disease; adult respiratory distress
syndrome. Groups comparable at baseline for Apache score; condition of pressure area at baseline not
discussed
Interventions 1. Kinetic Treatment Table (43)
7 ft x 3 ft padded, vinyl covered platform on central rotating pivot which turns through an arc every 1.7
seconds. Reported to be of value in respiratory failure
2. Routine 2 hourly turning on conventional beds (43)
Outcomes 1 patient developed small facial ulcer on Kinetic Treatment Table; none on conventional beds
Notes 3/86 (3%) patients lost to follow up
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Takala 1996
Methods Prevention Trial: RCT with 14 day follow up. Randomisation influenced by mattress availability therefore
not concealed
Participants Non trauma patients admitted to Intensive Care Unit who were expected to stay >5 days. Treatment
groups similar at baseline however not compared for degree of pressure sore risk
Interventions 1. Carital Optima (21): constant low pressure mattress comprising 21 double air bags on a base.
2. Standard hospital foam mattress (19): 10 cm thick foam density 35 kg/m3
Outcomes 1. No ulcers
2. 7/19 patients (37%) developed a total of 13 sores P<0.005. 9 ulcers were Grade 1A (erythema), 4 were
Grade 1B (superficial and limited to the dermis)
Notes 40% withdrawals; intention to treat analysis undertaken
Risk of bias
Item Authors’ judgement Description
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Takala 1996 (Continued)
Allocation concealment? No C - Inadequate
Taylor 1999
Methods Prevention Trial:
Discharge from hospital or death
Participants Hospital inpatients aged 16 or over, with intact skin, requiring a pressure relieving support
Interventions 1. Alternating pressure mattress with pressure redistributing cushion (Pegasus Trinova) (22)
2. Alternative alternating pressure system (unnamed) with pressure redistributing cushion (22)
Outcomes 1. TriNova 0/22
2. Control 2/22 (both ulcers superficial)
Notes Study underpowered. Comfort datawas not reported for control group.Nurse acceptability - Intervention:
good to very good n=15;
acceptable n=1;
Controls:
good to very good n=9;
acceptable n=11
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Theaker 2005
Methods Prevention RCT: follow up until two weeks after discharge from ICU
Participants Recruitment was from an IC unit. Eligible participants were deemed at high risk of pressure ulcer devel-
opment (from a set of five predetermined factors; details not provided but reference given) and aged 18
yeras or over. Patients with pressure sores on admission were excluded. Baseline data presented by outcome
so difficult to assess
Interventions 1. KCI TheraPulse bed (30)
2. Hill-Rom Duo mattress (32)
No further details about the devices given
Outcomes Number of participants with incidence pressure ulcer (assessed every 8 hours; blinded outcome assess-
ment*). All grades (not given by group, stated that most were grade 2 with one grade 3):
1. TheraPulse 3/30
2. Duo 6/32
8 of the 9 ulcers were heel ulcers.
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Theaker 2005 (Continued)
Notes Participant lost not mentioned. * Trial is described as unblinded, but the methods tdescribe blinded
outcome assessment with photographs
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - adequate envelopes opened by independent per-
son.
Tymec 1997
Methods Prevention Trial
Participants 52 patients admitted to selected nursing units of a large hospital with a Braden score of <16 (risk); intact
skin on heels. 23 women and 29 men aged 27-90 years, mean age 66.6±16.5 yrs. Mean Braden score on
admission 11.8. 21 patients with respiratory conditions, 6 with cancer, 5 with CVA
Interventions Factorial design evaluating effect of heel elevation device plus positioning and order of positioning.
1. Foot Waffle (FDA approved, non abrasive vinyl boot with built in foot cradle and inflated air chamber)
2. Hospital pillow under both legs from below knee to the Achilles tendon. Unclear how many patients
in each group
Outcomes Number of pressure ulcers developed
1. Foot Waffle, 6
2. Hospital pillow, 2 Denominators unclear
Notes Do not appear to be any losses
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - unclear
Vanderwee 2005
Methods Prevention RCT:
Participants Recruitment was from 19 surgical, internal medicine or geriatric hospital wards. Eligible patients were
deemed at risk of pressure ulcers (Braden score less than 17) or had at least one grade 1 ulcer, aged 18
years or over and had an expected hospital stay of at least 3 days and were not contrindicated fro turning.
Particpants were exlcuded if they had a grade 2 or above pressure ulcer, weighted more than 140 kgs.
Participants well balanced at baseline
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Vanderwee 2005 (Continued)
Interventions 1. APAM (Alpha X-cell, Huntleigh healthcare) generates alternating high and low interface pressure
between the body and support by alternating inflation and deflation. Sitting protocol with air cushion
(Airtech, Huntleigh). No turning protocol. (222)
2. Visco-elastic foam mattress (Tempur, Tempur-World). Sitting protocol with air cushion (Airtech,
Huntleigh). Turning every 4 hrs (225)
Outcomes Number of participants with incidence pressure ulcer (assessed daily by ward nurse; grade 1 exlcuded):
Grade 2 to 4 pressure ulcers(ns)
1. APAM 15.3% (34/222) 26 Grade 2; 8 Grade 3 or 4
2. Visco 15.6% (35/225) 33 Grade 2; 2 Grade 3 or 4
Notes No significant difference in incidence of pressure ulcers (grade 2-4) between the groups. There were
significantly more heel pressure ulcers in the control group (p=0.006). However, authors note that patients
nursed on an APAM seemed to develop more sever pressure ulcers
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate (sequentially numbered envelopes)
Vyhlidal 1997
Methods Prevention Trial: RCT with 10-21 day follow up. Allocation to surfaces achieved by investigator drawing
assignment out of a hat therefore extent of concealment inadequate
Participants Patients newly admitted to a skilled nursing facility; estimated stay at least 10 days; free of pressure ulcers
but at risk (Braden score <18 with subscale score of <3 in sensory perception, mobility or activity levels)
Diagnoses: musculoskeletal 45% cardiovascular 27.5% neurological 12.4% others 15%
Patients in the MAXIFLOAT group were younger though not significantly. Braden Scale scores (risk of
pressure ulcer development) similar between groups at baseline Patients in the MAXIFLOAT group were
significantly heavier and stayed on the mattress longer than the Iris group
Interventions 1. IRIS 3000; 4” thick foam overlay with dimpled surface (20)
2. MAXIFLOAT; mattress replacement in 5 sections (20). The mattress has a water/bacteria repellent
top cover; is made of 1.5” thick antimicrobial foam with a centre core of cut foam; has a nonremovable
polyester fibre heel pillow and a water/bacteria proof bottom cover.
Subjects in both groups received standards of care according to the protocols of the organisation
Outcomes All Grades of ulcer
1. IRIS 3000 60% (12/20)
Grade 1: 25% (4/20)
Grade 2: 40% (8/20)
2. MAXIFLOAT 25% (5/20)
Grade 1: 10% (2/20)
Grade 2: 15% (3/20)
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Vyhlidal 1997 (Continued)
P=0.025
Time to ulcer:
1. IRIS 3000 6.5 days
2. MAXIFLOAT 9.2 days (NS)
Notes No record of any withdrawals. The IRIS 3000 is an overlay which goes on an existing mattress resulting
(in the trial) in a bed height of 29 inches. One subject refused the IRIS because of the height of the bed.
IRIS is lighter at 6.9 lb than the MAXIFLOAT (25 lb) and easier to manipulate however the latter is still
lighter than standard hospital mattress (48 lb). IRIS can be sent home with patient. IRIS costs $38 cf.
$260 for MAXIFLOAT
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No C - Inadequate
Whitney 1984
Methods Prevention Trial: RCT with 8 day follow up. Method of allocation not stated - patients were ”selected at
random“ for each group
Participants Patients on medical-surgical units who were in bed for 20 hours daily. Most patients had relatively little
skin breakdown. Ages ranged from 19 - 91 years; mean 63.2 years. Majority of patients were confused,
lethargic, stuporous. Only 39% classed as mentally alert
Baseline data not presented
Interventions 1. Alternating pressure mattress (25)
Consisted of 134 3” diameter air cells. 3 minute cycle
2. Convoluted foam pad (Eggcrate) (26)
Patients in both groups were turned every two hours
Outcomes Changes in skin condition did not differ significantly between patients using the alternating pressure air
mattress and the foam mattress (better: 20% vs 19%; same: 60% vs 58%; worse 20% vs 23%)
Notes 4 patients died. Analysis by intention to treat. Alternating pressure mattress: pump maintenance was
costly, patients objected to the movement. The alternating mattress was more easily cleaned and retained
its original properties over several weeks compared to the foam which compressed and flattened
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Allocation concealment rated as:
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A Adequate
B Unclear
C Inadequate
D Not used
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Allen 1993 No clinical outcomes, interface pressure only recorded
Andrews 1989 Not an RCT
Ballard 1997 Data recorded was comfort data no pressure sore outcomes
Barhyte1995 Not an RCT
Bliss 1967 Not an RCT. Patients were recruited to the trial based on their risk score
Bliss 1995 Whilst 8 surfaces were evaluated in this prospective trial, not all surfaces were in the trial at any time therefore
the surfaces were not truly compared with one another contemporaneously. Furthermore it was possible for
patients to be re-randomised back into the study, and this occurred frequently; there were a total of 457 mattress
trials reported in only 238 patients. The data are not presented by patient; only by mattress trial.
Duplicate citation of Bliss 1994
Braniff 1997 Healing and prevention outcome data not separated
Brienza 2001 Study of pressure measurement
Chaloner 1999 Not an RCT, Controlled clinical trial. Duplicate citation with Chaloner D 2000
Chaloner 2000 Not an RCT, randomisation corrupted, authors report that randomisation compromised on the basis of bed
availability
Colin 1996 No clinical outcomes recorded, only transcutaneous oxygen tension measurements were taken
Conine 1991 Not an RCT
deBoisblanc 1993 Outcome incidence of pneumonia, no pressure sore outcomes
Defloor 2000 Does not compare surfaces
Defloor 2004 Compares turning
Flam 1995 Outcome skin temperature and skin moiture level, no pressure sore outcomes
Fleischer 1997 Not an RCT
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(Continued)
Grindley 1996 Patients were crossed over between intervention groups at 3 days. Outcome used was the assessment of patient
comfort
Gunningberg 1998 Not an RCT. Study of risk calculation rather than prevention
Hampton 1998 Not an RCT
Hawkins 1997 Not an RCT.
Inman 1999 Comparison of a bed rental versus a bed purchase strategy not a comparison of surfaces
Jacksich 1997 Not an RCT
Jesurum 1996 Not an RCT
Koo 1995 Not an RCT, study of interface pressure in healthy volunteers
Marchand 1993 Not an RCT
Ooka 1995 Quasi randomised trial design
Phillips 1999 N of 1 trial design
Regan 1995 This study reports an audit of pressure sore incidence after implementation of a comprehensive pressure sore
policy; it is not a prospective RCT
Reynolds 1994 Not an RCT
Rosenthal 1996 Not an RCT
Scott 1995 Ongoing study
Scott 1999 No clinical outcomes, healthy volunteer study of interface pressures
Scott 2000 Not an RCT of beds and mattresses
Stoneberg 1986 Historical control group
Suarez 1995 Controlled clinical trial which records only pressure measurements
Takala 94 Not an RCT, outcome measure of interface pressure
Thomas 1994 Not an RCT
Torra i Bou 2002 Evaluates dressings
Wells 1984 Interface pressure measurements only recorded
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(Continued)
Wild 1991 Interface pressure measurements
Zernike 1997 Use of eggcrate foam as a heel pressure relieving device, intervention not a bed or mattress. Incidence of pressure
sores not reported
Characteristics of studies awaiting assessment [ordered by study ID]
Berthe 2007
Methods
Participants
Interventions
Outcomes
Notes under assessment
Büchner 1995
Methods
Participants
Interventions
Outcomes
Notes awaiting translation
Defloor 1997
Methods
Participants
Interventions
Outcomes
Notes abstract only - awaiting further information
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Geelkerken 1994
Methods
Participants
Interventions
Outcomes
Notes awaiting translation
Haalboom 1994
Methods
Participants
Interventions
Outcomes
Notes awaiting translation
Holzgreve 1993
Methods
Participants
Interventions
Outcomes
Notes awaiting translation
Neander 1996
Methods
Participants
Interventions
Outcomes
Notes awaiting translation
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Zernike 1994
Methods
Participants
Interventions
Outcomes
Notes under assessment
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D A T A A N D A N A L Y S E S
Comparison 1. Constant low pressure supports v Standard foam mattresses (SFM)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 7 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Water 1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.2 Bead Bed 1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.3 Comfortex DeCube
mattress
1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.4 Softform mattress 1 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.5 Alternative foam 2 Risk Ratio (M-H, Random, 95% CI) Not estimable
1.6 Hi spec foam
mattress/cushion
1 Risk Ratio (M-H, Random, 95% CI) Not estimable
Comparison 2. Alternative Foam Mattress v Standard Foam Mattress
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 5 2016 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.21, 0.74]
1.1 Various alternatives
(pooled)
5 2016 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.21, 0.74]
2 Pressure ulcer incidence UK
studies only
4 1980 Risk Ratio (M-H, Random, 95% CI) 0.41 [0.19, 0.87]
Comparison 3. Comparisons Between Alternative Foam Supports
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 3 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 alternative foam v
standard foam
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Maxifloat Foam Mattress
v Iris Foam Overlay
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Solid Foam v Convoluted
Foam
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Comparison 4. Comparisons Between CLP Supports
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 8 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Sofflex v ROHO 1 84 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.16, 2.47]
1.2 Optima v SFM 1 40 Risk Ratio (M-H, Random, 95% CI) 0.06 [0.00, 0.99]
1.3 Gel Mattress v Air-filled
Overlay
1 66 Risk Ratio (M-H, Random, 95% CI) 0.8 [0.24, 2.72]
1.4 Static Air Mattress v Water
Mattress
1 37 Risk Ratio (M-H, Random, 95% CI) 0.42 [0.04, 4.29]
1.5 Foam Overlay v Silicore
Overlay
1 68 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.64, 2.14]
1.6 Sheepskin v no sheepskin 2 738 Risk Ratio (M-H, Random, 95% CI) 0.42 [0.22, 0.81]
1.7 Foam support surface v no
support
1 69 Risk Ratio (M-H, Random, 95% CI) 0.15 [0.05, 0.47]
Comparison 5. Alternating Pressure v Standard Foam Mattress
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 409 Risk Ratio (M-H, Fixed, 95% CI) 0.31 [0.17, 0.58]
Comparison 6. Alternating Pressure v Constant Low Pressure
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 10 1606 Risk Ratio (M-H, Random, 95% CI) 0.85 [0.64, 1.13]
1.1 AP (various) v CLP
(various)
1 230 Risk Ratio (M-H, Random, 95% CI) 0.38 [0.22, 0.66]
1.2 AP v Silicore or Foam
Overlay
4 331 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.72, 1.16]
1.3 AP v Water or Static Air
Mattress
3 458 Risk Ratio (M-H, Random, 95% CI) 1.31 [0.51, 3.35]
1.4 AP v continuous low
pressure mattress
1 140 Risk Ratio (M-H, Random, 95% CI) 2.06 [0.19, 22.18]
1.5 AP v Visco-elastic foam
mattress
1 447 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.64, 1.52]
2 AP devices versus silicore or
foam overlay
4 331 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.71, 1.17]
3 AP devices versus water or static
air mattress
3 458 Risk Ratio (M-H, Random, 95% CI) 1.31 [0.51, 3.35]
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Comparison 7. AP and CLP in ICU/Post ICU (Factorial Design)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Std ICU/SFM post-ICU
v Nimbus AP ICU/SFM
post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Std ICU/SFM post-ICU
v Std ICU/Tempur CLP
post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Nimbus AP ICU/SFM
post-ICU v Std ICU/Tempur
CLP post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 Std ICU/SFM post-ICU v
Nimbus AP ICU/Tempur CLP
post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 Nimbus AP ICU/SFM
post-ICU v Nimbus
ICU/Tempur post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.6 Std ICU/Tempur
post-ICU v Nimbus
ICU/Tempur post-ICU
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 8. Comparisons Between Alternating Pressure Devices
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 5 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Airwave v Large Cell
Ripple
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Airwave v Pegasus
Carewave
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Trinova v control 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.4 AP Overlay v AP Mattress 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.5 TheraPulse v Duo 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Comparison 9. Low Air Loss v Standard Bed
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 3 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Pressure incidence pooled 2 221 Risk Ratio (M-H, Random, 95% CI) 0.33 [0.16, 0.67]
3 Incidence of patients developing
multiple sores
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 10. Air-Fluidised Therapy v Dry Flotation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Rate of wound breakdown 1 12 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.20, 4.95]
Comparison 11. Kinetic Treatment Table v Standard
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 12. Operating Table Overlay v No Overlay
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Viscoelastic polymer pad v
No overlay
1 416 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.33, 0.85]
1.2 Viscoelastic foam overlay
v No overlay
1 175 Risk Ratio (M-H, Random, 95% CI) 1.53 [0.69, 3.39]
62Support surfaces for pressure ulcer prevention (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 13. Micropulse System for Surgical Patients
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 2 368 Risk Ratio (M-H, Fixed, 95% CI) 0.21 [0.06, 0.70]
Comparison 14. Seat Cushions
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pressure ulcer incidence 4 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Slab Foam v Bespoke
Contoured Foam
2 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.2 Jay Gel Cushion v Foam 1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
1.3 Pressure reducing cushion
v standard foam cushion
1 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
63Support surfaces for pressure ulcer prevention (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.1. Comparison 1 Constant low pressure supports v Standard foam mattresses (SFM), Outcome 1
Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 1 Constant low pressure supports v Standard foam mattresses (SFM)
Outcome: 1 Pressure ulcer incidence
Study or subgroup CLP SFM Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Water
Andersen 1982 7/155 21/161 0.35 [ 0.15, 0.79 ]
2 Bead Bed
Goldstone 1982 5/32 21/43 0.32 [ 0.14, 0.76 ]
3 Comfortex DeCube mattress
Hofman 1994 4/17 13/19 0.34 [ 0.14, 0.85 ]
4 Softform mattress
Gray 1994a 6/90 27/80 0.20 [ 0.09, 0.45 ]
5 Alternative foam
Collier 1996 0/130 0/9 Not estimable
Santy 1994 42/441 17/64 0.36 [ 0.22, 0.59 ]
6 Hi spec foam mattress/cushion
Russell 2002 48/562 66/604 0.78 [ 0.55, 1.11 ]
0.1 0.2 0.5 1 2 5 10
Favours CLP Favours SFM
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Analysis 2.1. Comparison 2 Alternative Foam Mattress v Standard Foam Mattress, Outcome 1 Pressure
ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 2 Alternative Foam Mattress v Standard Foam Mattress
Outcome: 1 Pressure ulcer incidence
Study or subgroup Alternative Foam Std Foam Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Various alternatives (pooled)
Collier 1996 0/130 0/9 Not estimable
Gray 1994a 6/90 27/80 21.3 % 0.20 [ 0.09, 0.45 ]
Hofman 1994 4/17 13/19 19.8 % 0.34 [ 0.14, 0.85 ]
Russell 2002 48/562 66/604 30.8 % 0.78 [ 0.55, 1.11 ]
Santy 1994 42/441 17/64 28.1 % 0.36 [ 0.22, 0.59 ]
Total (95% CI) 1240 776 100.0 % 0.40 [ 0.21, 0.74 ]
Total events: 100 (Alternative Foam), 123 (Std Foam)
Heterogeneity: Tau2 = 0.30; Chi2 = 13.24, df = 3 (P = 0.004); I2 =77%
Test for overall effect: Z = 2.89 (P = 0.0039)
0.01 0.1 1 10 100
Favours Alternative Favours SFM
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Analysis 2.2. Comparison 2 Alternative Foam Mattress v Standard Foam Mattress, Outcome 2 Pressure
ulcer incidence UK studies only.
Review: Support surfaces for pressure ulcer prevention
Comparison: 2 Alternative Foam Mattress v Standard Foam Mattress
Outcome: 2 Pressure ulcer incidence UK studies only
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Collier 1996 0/130 0/9 Not estimable
Gray 1994a 6/90 27/80 27.5 % 0.20 [ 0.09, 0.45 ]
Russell 2002 48/562 66/604 37.6 % 0.78 [ 0.55, 1.11 ]
Santy 1994 42/441 17/64 34.8 % 0.36 [ 0.22, 0.59 ]
Total (95% CI) 1223 757 100.0 % 0.41 [ 0.19, 0.87 ]
Total events: 96 (Treatment), 110 (Control)
Heterogeneity: Tau2 = 0.37; Chi2 = 12.41, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 2.31 (P = 0.021)
0.1 0.2 0.5 1 2 5 10
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Analysis 3.1. Comparison 3 Comparisons Between Alternative Foam Supports, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 3 Comparisons Between Alternative Foam Supports
Outcome: 1 Pressure ulcer incidence
Study or subgroup Foam 1 Foam 2 Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 alternative foam v standard foam
Santy 1994 42/441 17/64 0.36 [ 0.22, 0.59 ]
2 Maxifloat Foam Mattress v Iris Foam Overlay
Vyhlidal 1997 5/20 12/20 0.42 [ 0.18, 0.96 ]
3 Solid Foam v Convoluted Foam
Kemp 1993 12/39 21/45 0.66 [ 0.37, 1.16 ]
0.1 0.2 0.5 1 2 5 10
Favours Foam 1 Favours Foam 2
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Analysis 4.1. Comparison 4 Comparisons Between CLP Supports, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 4 Comparisons Between CLP Supports
Outcome: 1 Pressure ulcer incidence
Study or subgroup CLP1 CLP2 Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Sofflex v ROHO
Cooper 1998 3/41 5/43 100.0 % 0.63 [ 0.16, 2.47 ]
Subtotal (95% CI) 41 43 100.0 % 0.63 [ 0.16, 2.47 ]
Total events: 3 (CLP1), 5 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
2 Optima v SFM
Takala 1996 0/21 7/19 100.0 % 0.06 [ 0.00, 0.99 ]
Subtotal (95% CI) 21 19 100.0 % 0.06 [ 0.00, 0.99 ]
Total events: 0 (CLP1), 7 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 1.96 (P = 0.050)
3 Gel Mattress v Air-filled Overlay
Lazzara 1991 4/33 5/33 100.0 % 0.80 [ 0.24, 2.72 ]
Subtotal (95% CI) 33 33 100.0 % 0.80 [ 0.24, 2.72 ]
Total events: 4 (CLP1), 5 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
4 Static Air Mattress v Water Mattress
Sideranko 1992 1/20 2/17 100.0 % 0.43 [ 0.04, 4.29 ]
Subtotal (95% CI) 20 17 100.0 % 0.42 [ 0.04, 4.29 ]
Total events: 1 (CLP1), 2 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
5 Foam Overlay v Silicore Overlay
Stapleton 1986 14/34 12/34 100.0 % 1.17 [ 0.64, 2.14 ]
Subtotal (95% CI) 34 34 100.0 % 1.17 [ 0.64, 2.14 ]
Total events: 14 (CLP1), 12 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
6 Sheepskin v no sheepskin
Jolley 2004 21/218 37/223 51.0 % 0.58 [ 0.35, 0.96 ]
McGowan 2000 14/155 43/142 49.0 % 0.30 [ 0.17, 0.52 ]
0.002 0.1 1 10 500
Favours CLP1 Favours CLP2
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(. . . Continued)
Study or subgroup CLP1 CLP2 Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Subtotal (95% CI) 373 365 100.0 % 0.42 [ 0.22, 0.81 ]
Total events: 35 (CLP1), 80 (CLP2)
Heterogeneity: Tau2 = 0.15; Chi2 = 3.03, df = 1 (P = 0.08); I2 =67%
Test for overall effect: Z = 2.60 (P = 0.0094)
7 Foam support surface v no support
Cadue 2008 3/35 19/34 100.0 % 0.15 [ 0.05, 0.47 ]
Subtotal (95% CI) 35 34 100.0 % 0.15 [ 0.05, 0.47 ]
Total events: 3 (CLP1), 19 (CLP2)
Heterogeneity: not applicable
Test for overall effect: Z = 3.27 (P = 0.0011)
0.002 0.1 1 10 500
Favours CLP1 Favours CLP2
Analysis 5.1. Comparison 5 Alternating Pressure v Standard Foam Mattress, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 5 Alternating Pressure v Standard Foam Mattress
Outcome: 1 Pressure ulcer incidence
Study or subgroup Alternating Pressure SFM Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Andersen 1982 7/166 21/161 61.4 % 0.32 [ 0.14, 0.74 ]
Sanada 2003 6/55 10/27 38.6 % 0.29 [ 0.12, 0.73 ]
Total (95% CI) 221 188 100.0 % 0.31 [ 0.17, 0.58 ]
Total events: 13 (Alternating Pressure), 31 (SFM)
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 3.69 (P = 0.00022)
Test for subgroup differences: Not applicable
0.02 0.1 1 10 50
Favours AP Favours SFM
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Analysis 6.1. Comparison 6 Alternating Pressure v Constant Low Pressure, Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 6 Alternating Pressure v Constant Low Pressure
Outcome: 1 Pressure ulcer incidence
Study or subgroup AP CLP Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 AP (various) v CLP (various)
Gebhardt 1994 15/115 39/115 15.7 % 0.38 [ 0.22, 0.66 ]
Subtotal (95% CI) 115 115 15.7 % 0.38 [ 0.22, 0.66 ]
Total events: 15 (AP), 39 (CLP)
Heterogeneity: not applicable
Test for overall effect: Z = 3.49 (P = 0.00048)
2 AP v Silicore or Foam Overlay
Conine 1990 39/72 45/76 26.1 % 0.91 [ 0.69, 1.21 ]
Daechsel 1985 4/16 4/16 4.9 % 1.00 [ 0.30, 3.32 ]
Stapleton 1986 11/32 26/68 14.7 % 0.90 [ 0.51, 1.58 ]
Whitney 1984 5/25 6/26 6.1 % 0.87 [ 0.30, 2.48 ]
Subtotal (95% CI) 145 186 51.8 % 0.91 [ 0.72, 1.16 ]
Total events: 59 (AP), 81 (CLP)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 3 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
3 AP v Water or Static Air Mattress
Andersen 1982 7/166 7/155 6.3 % 0.93 [ 0.34, 2.60 ]
Price 1999 1/40 2/40 1.4 % 0.50 [ 0.05, 5.30 ]
Sideranko 1992 5/20 3/37 4.1 % 3.08 [ 0.82, 11.59 ]
Subtotal (95% CI) 226 232 11.8 % 1.31 [ 0.51, 3.35 ]
Total events: 13 (AP), 12 (CLP)
Heterogeneity: Tau2 = 0.18; Chi2 = 2.67, df = 2 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.57 (P = 0.57)
4 AP v continuous low pressure mattress
Cavicchioli 2007 2/69 1/71 1.4 % 2.06 [ 0.19, 22.18 ]
Subtotal (95% CI) 69 71 1.4 % 2.06 [ 0.19, 22.18 ]
Total events: 2 (AP), 1 (CLP)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.55)
5 AP v Visco-elastic foam mattress
Vanderwee 2005 34/222 35/225 19.4 % 0.98 [ 0.64, 1.52 ]
0.002 0.1 1 10 500
Favours AP Favours CLP
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(. . . Continued)
Study or subgroup AP CLP Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Subtotal (95% CI) 222 225 19.4 % 0.98 [ 0.64, 1.52 ]
Total events: 34 (AP), 35 (CLP)
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.94)
Total (95% CI) 777 829 100.0 % 0.85 [ 0.64, 1.13 ]
Total events: 123 (AP), 168 (CLP)
Heterogeneity: Tau2 = 0.06; Chi2 = 13.69, df = 9 (P = 0.13); I2 =34%
Test for overall effect: Z = 1.09 (P = 0.28)
0.002 0.1 1 10 500
Favours AP Favours CLP
Analysis 6.2. Comparison 6 Alternating Pressure v Constant Low Pressure, Outcome 2 AP devices versus
silicore or foam overlay.
Review: Support surfaces for pressure ulcer prevention
Comparison: 6 Alternating Pressure v Constant Low Pressure
Outcome: 2 AP devices versus silicore or foam overlay
Study or subgroup AP device CLP device Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Conine 1990 39/72 45/76 62.3 % 0.91 [ 0.69, 1.21 ]
Daechsel 1985 4/16 4/16 5.7 % 1.00 [ 0.30, 3.32 ]
Stapleton 1986 11/32 26/68 23.7 % 0.90 [ 0.51, 1.58 ]
Whitney 1984 5/25 6/26 8.4 % 0.87 [ 0.30, 2.48 ]
Total (95% CI) 145 186 100.0 % 0.91 [ 0.71, 1.17 ]
Total events: 59 (AP device), 81 (CLP device)
Heterogeneity: Chi2 = 0.03, df = 3 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.73 (P = 0.47)
0.1 0.2 0.5 1 2 5 10
Favours AP device Favours CLP device
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Analysis 6.3. Comparison 6 Alternating Pressure v Constant Low Pressure, Outcome 3 AP devices versus
water or static air mattress.
Review: Support surfaces for pressure ulcer prevention
Comparison: 6 Alternating Pressure v Constant Low Pressure
Outcome: 3 AP devices versus water or static air mattress
Study or subgroup AP device CLP device Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Andersen 1982 7/166 7/155 50.2 % 0.93 [ 0.34, 2.60 ]
Price 1999 1/40 2/40 14.0 % 0.50 [ 0.05, 5.30 ]
Sideranko 1992 5/20 3/37 35.8 % 3.08 [ 0.82, 11.59 ]
Total (95% CI) 226 232 100.0 % 1.31 [ 0.51, 3.35 ]
Total events: 13 (AP device), 12 (CLP device)
Heterogeneity: Tau2 = 0.18; Chi2 = 2.67, df = 2 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.57 (P = 0.57)
0.002 0.1 1 10 500
Favours AP device Favours CLP device
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Analysis 7.1. Comparison 7 AP and CLP in ICU/Post ICU (Factorial Design), Outcome 1 Pressure ulcer
incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 7 AP and CLP in ICU/Post ICU (Factorial Design)
Outcome: 1 Pressure ulcer incidence
Study or subgroup Comparison 1 Comparison 2 Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Std ICU/SFM post-ICU v Nimbus AP ICU/SFM post-ICU
Laurent 1997 4/80 10/80 0.40 [ 0.13, 1.22 ]
2 Std ICU/SFM post-ICU v Std ICU/Tempur CLP post-ICU
Laurent 1997 14/80 11/75 1.19 [ 0.58, 2.46 ]
3 Nimbus AP ICU/SFM post-ICU v Std ICU/Tempur CLP post-ICU
Laurent 1997 10/80 11/75 0.85 [ 0.38, 1.89 ]
4 Std ICU/SFM post-ICU v Nimbus AP ICU/Tempur CLP post-ICU
Laurent 1997 14/80 10/77 1.35 [ 0.64, 2.85 ]
5 Nimbus AP ICU/SFM post-ICU v Nimbus ICU/Tempur post-ICU
Laurent 1997 10/80 10/77 0.96 [ 0.42, 2.18 ]
6 Std ICU/Tempur post-ICU v Nimbus ICU/Tempur post-ICU
Laurent 1997 11/75 10/77 1.13 [ 0.51, 2.50 ]
0.1 0.2 0.5 1 2 5 10
Favours Comparison 1 Favours Comparison 2
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Analysis 8.1. Comparison 8 Comparisons Between Alternating Pressure Devices, Outcome 1 Pressure
ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 8 Comparisons Between Alternating Pressure Devices
Outcome: 1 Pressure ulcer incidence
Study or subgroup AP device Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Airwave v Large Cell Ripple
Exton-Smith 1982 5/31 12/31 0.42 [ 0.17, 1.04 ]
2 Airwave v Pegasus Carewave
Hampton 1997 0/36 0/39 Not estimable
3 Trinova v control
Taylor 1999 0/22 2/22 0.20 [ 0.01, 3.94 ]
4 AP Overlay v AP Mattress
Nixon 2006 106/989 101/982 1.04 [ 0.81, 1.35 ]
5 TheraPulse v Duo
Theaker 2005 3/30 6/32 0.53 [ 0.15, 1.94 ]
0.1 0.2 0.5 1 2 5 10
Favours AP Favours Control
Analysis 9.1. Comparison 9 Low Air Loss v Standard Bed, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 9 Low Air Loss v Standard Bed
Outcome: 1 Pressure ulcer incidence
Study or subgroup LAL Standard ICU Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bennett 1998 8/42 4/56 2.67 [ 0.86, 8.27 ]
Cobb 1997 6/62 12/61 0.49 [ 0.20, 1.23 ]
Inman 1993 6/49 25/49 0.24 [ 0.11, 0.53 ]
0.1 0.2 0.5 1 2 5 10
Favours LAL Favours Std ICU
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Analysis 9.2. Comparison 9 Low Air Loss v Standard Bed, Outcome 2 Pressure incidence pooled.
Review: Support surfaces for pressure ulcer prevention
Comparison: 9 Low Air Loss v Standard Bed
Outcome: 2 Pressure incidence pooled
Study or subgroup LAL Standard ICU Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Cobb 1997 6/62 12/61 45.0 % 0.49 [ 0.20, 1.23 ]
Inman 1993 6/49 25/49 55.0 % 0.24 [ 0.11, 0.53 ]
Total (95% CI) 111 110 100.0 % 0.33 [ 0.16, 0.67 ]
Total events: 12 (LAL), 37 (Standard ICU)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.35, df = 1 (P = 0.25); I2 =26%
Test for overall effect: Z = 3.09 (P = 0.0020)
Test for subgroup differences: Not applicable
0.005 0.1 1 10 200
Favours LAL Favours Std ICU
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Analysis 9.3. Comparison 9 Low Air Loss v Standard Bed, Outcome 3 Incidence of patients developing
multiple sores.
Review: Support surfaces for pressure ulcer prevention
Comparison: 9 Low Air Loss v Standard Bed
Outcome: 3 Incidence of patients developing multiple sores
Study or subgroup LAL Standard ICU Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Inman 1993 1/49 12/49 0.08 [ 0.01, 0.62 ]
0.01 0.1 1 10 100
Favours LAL Favours Std ICU
Analysis 10.1. Comparison 10 Air-Fluidised Therapy v Dry Flotation, Outcome 1 Rate of wound breakdown.
Review: Support surfaces for pressure ulcer prevention
Comparison: 10 Air-Fluidised Therapy v Dry Flotation
Outcome: 1 Rate of wound breakdown
Study or subgroup AF Dry Flotation Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Economides 1995 2/6 2/6 100.0 % 1.00 [ 0.20, 4.95 ]
Total (95% CI) 6 6 100.0 % 1.00 [ 0.20, 4.95 ]
Total events: 2 (AF), 2 (Dry Flotation)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
0.01 0.1 1 10 100
Favours AF Favours DF
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Analysis 11.1. Comparison 11 Kinetic Treatment Table v Standard, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 11 Kinetic Treatment Table v Standard
Outcome: 1 Pressure ulcer incidence
Study or subgroup KTT Standard Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Gentilello 1988 8/27 10/38 1.13 [ 0.51, 2.48 ]
Summer 1989 1/43 0/43 3.00 [ 0.13, 71.65 ]
0.01 0.1 1 10 100
Favours KTT Favours Std
Analysis 12.1. Comparison 12 Operating Table Overlay v No Overlay, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 12 Operating Table Overlay v No Overlay
Outcome: 1 Pressure ulcer incidence
Study or subgroup Overlay No Overlay Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Viscoelastic polymer pad v No overlay
Nixon 1998 22/205 43/211 100.0 % 0.53 [ 0.33, 0.85 ]
Subtotal (95% CI) 205 211 100.0 % 0.53 [ 0.33, 0.85 ]
Total events: 22 (Overlay), 43 (No Overlay)
Heterogeneity: not applicable
Test for overall effect: Z = 2.64 (P = 0.0083)
2 Viscoelastic foam overlay v No overlay
Feuchtinger 2006 13/85 9/90 100.0 % 1.53 [ 0.69, 3.39 ]
Subtotal (95% CI) 85 90 100.0 % 1.53 [ 0.69, 3.39 ]
Total events: 13 (Overlay), 9 (No Overlay)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.30)
0.005 0.1 1 10 200
Favours Overlay Favours No Overlay
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Analysis 13.1. Comparison 13 Micropulse System for Surgical Patients, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 13 Micropulse System for Surgical Patients
Outcome: 1 Pressure ulcer incidence
Study or subgroup Micropulse System Std Care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Aronovitch 1999 1/90 7/80 51.7 % 0.13 [ 0.02, 1.01 ]
Russell 2000 2/98 7/100 48.3 % 0.29 [ 0.06, 1.37 ]
Total (95% CI) 188 180 100.0 % 0.21 [ 0.06, 0.70 ]
Total events: 3 (Micropulse System), 14 (Std Care)
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.53 (P = 0.011)
0.01 0.1 1 10 100
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Analysis 14.1. Comparison 14 Seat Cushions, Outcome 1 Pressure ulcer incidence.
Review: Support surfaces for pressure ulcer prevention
Comparison: 14 Seat Cushions
Outcome: 1 Pressure ulcer incidence
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Slab Foam v Bespoke Contoured Foam
Conine 1993 85/125 84/123 1.00 [ 0.84, 1.18 ]
Lim 1988 19/26 18/26 1.06 [ 0.75, 1.49 ]
2 Jay Gel Cushion v Foam
Conine 1994 17/68 30/73 0.61 [ 0.37, 1.00 ]
3 Pressure reducing cushion v standard foam cushion
Geyer 2001 6/15 10/17 0.68 [ 0.33, 1.42 ]
0.2 0.5 1 2 5
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A D D I T I O N A L T A B L E S
Table 1. Quality Assessment of Included Studies and sample sizes
Trial Clear inc &
excl
Sample size
(arms)
A priori
calc
True RCT Baseline
comp
Blind out-
come assess
Grade 1 sore
exclude
Intervent
well docum
Andersen
1982
yes 482(3) yes no yes no yes no
Aronovitch
1999
yes 217(2) no no yes yes yes yes
Bennett
1998
yes 98(2) no no yes no yes no
Cadue 2008 yes 70/69 (2) no yes yes unclear no yes
Cavicchioli
2007
yes 170 (2) no unclear yes yes no yes
Cobb 1997 yes 123 (2) no yes no unclear no yes
Collier 1996 no 99(9) no yes no no n/a yes
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Table 1. Quality Assessment of Included Studies and sample sizes (Continued)
Conine
1990
yes 187(2) no no yes yes yes no
Conine
1993
yes 288(2) no unclear yes yes unclear yes
Conine
1994
yes 163(2) no no yes yes yes yes
Cooper
1998
yes 100(2) no yes yes no yes yes
Daechsel
1985
yes 32(2) no no yes no no yes
Economides
1995
yes 12(2) no yes yes no yes yes
Ewing 1964 no 30(2) no no no no no yes
Exton-
Smith 1982
yes 66(2) no on yes no yes yes
Feuchtinger
2006
yes 175 (2) yes Unclear yes yes no yes
Gebhardt
1994
yes 230(2) no no yes no yes yes
Gentilello
1988
yes 65(2) no yes yes no no yes
Geyer 2001 yes 32 (2) no yes yes yes unclear yes
Gilcreast
2005
yes 338 (2) yes yes no unclear no yes
Goldstone
1982
yes 75(2) no no yes no no yes
Gray 1994b yes 100(2) no yes yes yes yes no
Gray 1994a yes 170(2) no yes yes no yes yes
Gunning-
berg
2000
yes 101(2) yes yes yes yes yes yes
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Table 1. Quality Assessment of Included Studies and sample sizes (Continued)
Hampton
1997
yes 75(2) no no no no no yes
Hofman
1994
yes 44(2) yes no yes no yes yes
Inman 1993 yes 100(2) yes no yes no yes no
Jolley 2004 yes 539 (2) Unclear yes yes no no yes
Kemp 1993 yes 84(2) no yes yes yes no no
Keogh 2001 yes 100(2) yes yes yes unclear unclear yes
Laurent
1997
yes 312(4) yes no yes no yes yes
Lazzara
1991
yes 74(2) no yes no no yes no
Lim 1988 yes 62(2) no no yes yes yes yes
McGowan
2000
yes 297(2) yes no yes no no yes
Nixon 1998 yes 446(2) yes yes yes yes yes yes
Nixon 2006 yes 1972 (2) yes yes yes no yes yes
Price 1999 yes 80(2) yes yes yes no yes no
Russell 2000 yes 198(2) no yes yes no no yes
Russell 2002 yes 1166(2) yes yes yes no no yes
Sanada
2003
yes 103 (3) Unclear yes yes no no yes
Santy 1994 yes 505(5) yes yes yes no no yes
Schultz
1999
yes 413(2) yes yes yes yes no no
Sideranko
1992
yes 57(3) no no yes no no no
Stapleton
1986
yes 100(3) no no no no yes no
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Table 1. Quality Assessment of Included Studies and sample sizes (Continued)
Summer
1989
yes 83(2) no no yes no no yes
Takala 1996 yes 40(2) yes no yes no yes yes
Taylor 1999 yes 44(2) yes unclear yes unclear no yes
Theaker
2005
yes 62 (2) yes yes yes no Unclear yes
Tymec 1997 yes 52(2) yes no no no yes yes
Vanderwee
2005
yes 447 (2) yes yes yes no yes yes
Vyhlidal
1997
yes 40(2) no no yes no yes yes
Whitney
1984
no 51(2) no no no no no no
A P P E N D I C E S
Appendix 1. Search strategy for the first update of this review
The Wounds Group Specialised Trials Register was searched up to January 2004, this register is maintained by regular searching of the
following databases: CENTRAL, MEDLINE, EMBASE and CINAHL and hand searching conference proceedings.
The Cochrane Central Register of Controlled Trials (CENTRAL) was searched, Issue 4 2003 using the following strategy:
1. BEDS single term (MeSH)
2. (bed or beds or bedding)
3. mattress*
4. cushion*
5. foam or transfoam
6. overlay*
7. (pad or pads)
8. gel
9. (pressure near relie*)
10. (pressure near device*)
11. (pressure near reduction)
12. (pressure near reducing)
13. (positioning* or repositioning*)
14. ((low next pressure) and support*)
15. ((low next pressure) and device*)
16. (constant near pressure)
17. (alternat* near pressure)
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18. (air near suspension*)
19. (water near suspension*)
20. clinifloat
21. vaperm
22. therarest
23. maxifloat
24. sheepskin*
25. hammock*
26. (foot next waffle)
27. silicore
28. pegasus
29. (cairwave near therapy)
30. (turning near table*)
31. (kinetic near table*)
32. (kinetic near therapy)
33. (air next bag*)
34. (elevation near device*)
35. (static next air)
36. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10)
37. (#11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20)
38. (#21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30)
39. (#31 or #32 or #33 or #34 or #35)
40. (#36 or #37 or #38 or #39)
41. DECUBITUS ULCER single term (MeSH)
42. (decubitus next ulcer*)
43. (bed near ulcer*)
44. (bed near sore*)
45. (pressure near sore*)
46. (pressure near ulcer*)
47. (#41 or #42 or #43 or #44 or #45 or #46)
48. (#40 and #47)
WH A T ’ S N E W
Last assessed as up-to-date: 17 July 2008.
Date Event Description
14 April 2010 Amended Contact details updated.
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H I S T O R Y
Protocol first published: Issue 3, 1998
Review first published: Issue 2, 2000
Date Event Description
13 May 2009 Amended No changes - republished to fix technical problem.
18 July 2008 New citation required and conclusions have changed Second update with the inclusion of 11 additional trials.
18 July 2008 New search has been performed second update of review
23 April 2008 Amended Converted to new review format.
20 May 2004 New citation required and conclusions have changed First update (substantive amendment) published Issue 3,
2004. This review includes only trials which consider inter-
ventions which aim to prevent pressure ulcers. The title of
the review has been changed to more accurately reflect the
scope of the review
The original review: Beds, mattresses and cushions for pre-
venting and treating pressure ulcers. Cullum N, Deeks J,
Sheldon TA, Song F, Fletcher AW, has been substantially
updated and now forms the basis of a prevention review and
a separate treatment review
C O N T R I B U T I O N S O F A U T H O R S
NC conceived the original idea, wrote the protocol, extracted and analysed the data and drafted the original review, contributed to
both updates and is responsible for the final edit.
EMcI made inclusion decisions, extracted data, assessed study quality and contributed to the text for both updates.
SBS undertook searching, inclusion decisions, analysis and contributed text for both updates.
RL made inclusion decisions, extracted data, assessed study quality and contributed to the text for the first update.
JD made inclusion decisions, extracted data, assessed study quality and contributed to the text for the second update.
D E C L A R A T I O N S O F I N T E R E S T
Nicky Cullum was the Principal investigator in the PRESSURE Trial, one of the trials included in this review (Nixon 2006), however
she was not involved in the data extraction or analysis for this trial.
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Internal sources
• Department of Health Sciences, University of York, UK.
External sources
• NIHR (all versions), UK.
• NHS Health Technology Assessment Programme (original review), UK.
• National Institute of Clinical Excellence Guidelines Programme (first update), UK.
N O T E S
The original review: Beds, mattresses and cushions for preventing and treating pressure ulcers. Cullum N, Deeks J, Sheldon TA, Song
F, Fletcher AW, has been substantially updated and now forms the basis of a prevention review and a separate treatment review. The
review: Support surfaces for treating pressure ulcers is currently being updated.
This review: Support surfaces for pressure ulcer prevention has been prepared by Cullum N, McInnes E, Bell-Syer SEM, Legood R
and includes only trials which consider interventions which aim to prevent pressure ulcers. The title of the review has been changed to
more accurately reflect the scope of the review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Beds [standards]; Pressure Ulcer [∗prevention & control; therapy]; Randomized Controlled Trials as Topic
MeSH check words
Humans
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